Veeda is managing the study of Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine Check out our Assay List (Method Library) Our latest article on the Development and Execution of In Vivo Bioassays

Assay List ( Method Library)

CLICK HERE TO DOWNLOAD
  • Recently Validated Methods
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    1 4-Methyl amino antipyrine antipyrine Human Plasma K3EDTA LC/MS/MS Premier XE 300 90000
    2 Drospirenone Progestogen Human Plasma K3EDTA LC/MS/MS K3EDTA 0.20 100
    3 Erdosteine Thiol derivative Human Plasma K3EDTA LC/MS/MS Premier XE 15.00 3000
    4 Mesalamine Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 4000 2.0 3500
    5 Anti-inflammatory Iron Defficiency Anaemia Human Serum NA ICP OES Optima 8000 400.00 50000
    6 Total Iron Iron Defficiency Anaemia Human Serum NA ICP OES Optima 8000 400.00 800000
  • Premium Methods (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    1 4-Plex Amino acid (O-Acetyl-L-Carnitine, L- Carnitine, Creatine and L-Citrulline). Amino acids Human Plasma K3EDTA LC/MS/MS LCMS-8040 40.0
    80.0    		 8000
    16000
    2 Aspirin +
    Salicylic acid (Sensitive)    		 Psoriasis Human Plasma Na Heparin LC/MS/MS API 4000 2.00 500
    3 Amino Acids (20 amino acids) Amino Acids Human Plasma K3EDTA LC/MS/MS LCMS-8040 100
    150
    500
    1000
    2000    		 4000
    6000
    20000
    40000
    80000
    4 Amphotericin B (Free) Antifungal Human Plasma K3EDTA LC/MS/MS LCMS-8050 5.00 2500
    5 Amphotericin B (Liposomal ) Antifungal Human Plasma Sodium Heparin LC/MS/MS LCMS-8050 100 40000
    6 Aspirin anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 4000 5.00 3000
    7 Aspirin +
    Salicylic acid (Sensitive)    		 Analgesic Human Plasma Na Heparin LC/MS/MS API 3000 2.00
    150    		 1200
    10000
    8 Atorvastatin +
    2 - Hydroxy Atorvastatin+
    4 - Hydroxy Atorvastatin+
    Glimpride+
    Glimpride M1 Metabolite    		 Antihyperlipidemic
    Antidiabetic    		 Human Plasma K3EDTA LC/MS/MS API 4000 0.10
    0.10
    0.05
    0.50
    0.50    		 40
    40
    20
    200
    200
    9 5-Azacitidine Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 2500
    10 Bupropion +
    Hydroxy Bupropion+
    Erythro Bupropion +
    Threo Bupropion    		 Antidepressant and Smoking cessation Human Plasma Sodium Heparin LC/MS/MS Premier XE 3.00
    10.0
    3.00
    5.00    		 900
    3000
    900
    1500
    11 Bupropion + Hydroxy
    Bupropion +
    Erythro Bupropion +
    Threo Bupropion    		 Antidepressant Human Plasma Na Heparin LC/MS/MS Premier XE 1.00
    3.00
    0.80
    2.50    		 300
    900
    240
    750
    12 Bupropion +
    Hydroxy Bupropion+
    Erythrohydro Bupropion +
    Threohydro Bupropion    		 Antidepressant Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.60
    4.00
    0.30
    1.20    		 300
    2000
    150
    600
    13 Dabigatran(Total) Thrombin Inhibitor Human Plasma Sodium citrate LC/MS/MS LCMS-8050 1.00 400
    14 Disulfiram For Chronic Alcoholism Human Plasma Na Heparin LC/MS/MS API 3000 25.0 5000
    15 Docetaxel(Free) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 1.00 600
    16 Doxorubicin Metabolite (Doxorubicinol) Oestrogen
    Progestogen    		 Human Plasma Na Heparin LC/MS/MS API 4000 0.25 20
    17 Doxorubicin(Free) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 50.0 5000
    18 Doxorubicin(Liposomal) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 250 50000
    19 Doxorubicin (Total) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 250 50000
    20 Doxorubicin (Free) Anticancer Human Plasma K3EDTA LC/MS/MS API 5500 10.0 5000
  • Premium Methods (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    21 Doxorubicin (Liposomal)) Anticancer Human Plasma K3EDTA LC/MS/MS API 5500 150 60000
    22 Doxorubicin (Free ) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 10.0 2000
    23 Doxorubicin (Liposomal) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 150 60000
    24 Ergocalciferol Vitamin D2 Human Plasma K3EDTA LC/MS/MS API 5500 0.10 100
    25 Estrone Unconjugated +
    Estradiol Unconjugated +
    Norethindrone    		 Oestrogen
    Oestrogen
    Progestogen    		 Human Plasma K3EDTA LC/MS/MS API 5500 0.003
    0.001
    0.100    		 0.400
    0.133
    13.3
    26 Estrone (Total) Oestrogen Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.050 50.0
    27 Ethinyl Estradiol(Sensitive)
    + Levonorgestrel    		 Oestrogen
    Progestogen    		 Human Plasma K3EDTA LC/MS/MS API 5500 0.002
    0.100    		 0.250
    25.0
    28 Equilin Total +
    ∆8,9-dehydroestrone Total    		 Oestrogen Human Plasma K3EDTA LC/MS/MS API 5500 0.050
    0.025    		 8.00
    4.00
    29 Estrone Total Oestrogen Human Plasma K3EDTA LC/MS/MS API 5500 0.050 15.0
    30 Estrone Uncojugated + Equilin
    Unconjugated +
    ∆ 8,9 Dehydroestrone Unconjugated    		 Oestrogen Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.0030
    0.0045
    0.0045    		 0.400
    0.600
    0.600
    31 Estrone (Unconjugated) + Estradiol (Unconjugated) Oestrogen Human Plasma K3EDTA LC/MS/MS API 5500 0.003
    0.001    		 0.48
    0.16
    32 Fesoterodine + 5-OH Methyl Tolterodine Urinary Iincontinence Human Plasma K3EDTA LC/MS/MS API 4000 0.01
    0.02    		 7.5
    15.0
    33 Fingolimod + Fingolimod Phosphate Multiple sclerosis Human Blood K3EDTA LC/MS/MS API 5500 0.04
    0.04    		 5.00
    5.00
    34 Fingolimod + Fingolimod phosphate Multiple sclerosis Human Blood K3EDTA LC/MS/MS API 5500 0.010
    0.010    		 5.00
    5.00
    35 Fluphenazine Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.003 2.10
    36 (+)-3R 5S Fluvastatin +
    (-)-3S 5R Fluvastatin    		 Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.60
    0.60    		 300
    300
    37 Fluticasone Propionate Corticosteroid, Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.002 500
    38 Fluticasone Propionate Corticosteroid, Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.0008 1
    39 Formoterol Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.0004 0.20
    40 Isosorbide Dinitrate +
    Isosorbide 2-mono nitrate +
    Isosorbide 5-mono nitrate    		 Angina Pectoris, Congestive
    Heart Failure     		Human Plasma K3EDTA LC/MS/MS API 5500 0.40
    2.00
    2.00    		 100
    500
    500
  • Premium Methods (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    41 13-cis-Retinoic Acid+
    4-Keto 13-cis-Retinoic Acid    		 Vitamin A Human Plasma K3EDTA LC/MS/MS Premier XE 5.00
    10.0    		 1000
    2000
    42 2-Hydroxy Oleic Acid Synthetic derivative of Oleic Acid Human Plasma Na-Heparin LC/MS/MS API 4000 25.0 25000
    43 R-Ibuprofen+ S-Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS API 4000 1000 32000
    44 R-Ibuprofen + S-Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 200
    200    		 70000
    70000
    45 Isoniazide +
    Rifampicin +
    25 -Desacetyl Rifampicin+
    Ethambutol +
    Pyrazinamide    		 Antitubercular Human Plasma Na Heparin LC/MS/MS API 4000 60
    15
    25
    15
    200    		 6000
    1500
    2500
    1500
    20000
    46 R-Ketoprofen +
    S-Ketoprofen    		 NSAID Human Plasma K3EDTA LC/MS/MS API 4000 25.0
    25.0    		 15000
    15000
    47 R-Lercanidipine +
    S-Lercanidipine    		 Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025
    0.025    		 20.0
    20.0
    48 Lurasidone Metabolite 14283 Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 1000
    49 Metformin+
    Pioglitazone+
    Hydroxy Pioglitazone    		 Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 10.00 2400
    50 R-Metoprolol+
    S-Metoprolol     		Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 2.00 500
    51 S-Methyl N, N- Diethyl dithiocarbamate (Disulfiram Secondary Metabolite ) For Chronic Alcoholism (Disulfiram) Human Plasma Na Heparin LC/MS/MS API 3000 5.00 1000
    52 RSSS -Nebivolol + SRRR-Nebivolo Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 0.020
    0.020    		 6.00
    6.00
    53 N-Acetyl-L-Cysteine Chronic bronchopulmonary
    disease    		 Human Plasma K3EDTA LC/MS/MS LCMS-8040 20.0 4000
    54 Niacin + Nicotinuric Acid(Metabolite) Vitamin Human Plasma K3EDTA LC/MS/MS API 4000 5.00
    15.0    		 1000
    3000
    55 Nitroglycerin +
    1, 2-Dinitroglycerin +
    1, 3-Dinitroglycerin     		Vasodilator Human Plasma K3EDTA LC/MS/MS API 5500 0.020
    0.050
    0.050    		 2.00
    5.00
    5.00
    56 Nitroglycerin +
    1,2-Dinitroglycerin +
    1,3-Dinitroglycerin    		 Vasodilator Human Plasma K3EDTA LC/MS/MS API 5500 0.010
    0.020
    0.010    		 5.00
    10.0
    5.00
    57 Paclitaxel (Free, Unbound) Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 1.00 1500
    58 Paclitaxel (Free) Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 10.0 2000
    59 Penicillamine Chelating Agent Human Plasma K3EDTA LC/MS/MS Premier XE 15.0 4000
    60 Phenindione Anticoagulant/Vitamin K
    antagonist    		 Human Plasma K3EDTA LC/MS/MS API 4000 50.0 20000
  • Premium Methods (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    61 Prednisolone Corticosteroid Human Plasma K3EDTA LC/MS/MS API 3000 2.00 1000
    62 Propranolol (Total) + 4- Hydroxy Propranolol (Total) Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040 1.00
    0.500    		 500
    250
    63 cis & trans-Phytonadione Vitamin K Human Plasma K3EDTA LC/MS/MS API 4000 0.100
    0.100    		 150
    150
    64 R-Praziquantel +
    S-Praziquantel    		 Anthelmintic Human Plasma K3EDTA LC/MS/MS API 4000 2.00
    2.00    		 2000
    2000
    65 Progesterone Progestogen Human Plasma K3EDTA LC/MS/MS API 5500 0.025 25.0
    66 Propranolol Total +
    4-OH Propranolol Total     		Beta–adrenoceptor Blocking Agent Human Plasma K3EDTA LC/MS/MS Premier XE 2.00 500
    67 R-(+) -trans -tranylcypromine +
    S-(-) -trans-tranylcypromine    		 Antidepressant and Anxiolytic Human Plasma K3EDTA LC/MS/MS API 4000 0.100
    0.200     		40.0
    80.0
    68 Trientine + N1 -Acetyl triethylenetetramine Chelating agent Human Plasma K3EDTA LC/MS/MS API 3000 6.00
    10.0    		 11500
    2500
    69 Trientine +
    N1 -Acetyl triethylenetetramine + N1,N10 -
    Diacetyl triethylenetetramine    		 Chelating agent Human Plasma K3EDTA LC/MS/MS API 3000 10.0
    10.0
    3.00    		 2000
    2000
    600
    70 Rivastigmine(Sensitive) Alzheimer's & Parkinson's Disease Human Plasma K3EDTA LC/MS/MS Premier XE 0.05 20.0
    71 Tiopronin Cystinuria Human Plasma K3EDTA LC/MS/MS LCMS-8040 20.0 12000
    72 Tiotropium Anticholinergic Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.20 pg/mL 100 pg/mL
    73 R-Warfarin +
    S-Warfarin    		 Anticoagulant Human Plasma K3EDTA LC/MS/MS API 4000 1.00
    1.00    		 1000
    1000
  • Pharmacodynamic / Pharmacokinetic / Immunogenicity Determination
    (Validated Kit / LCMSMS Method)
    Sr. No. Activity/Marker Purpose Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    1 Nitrate Marker For the Activity of Nitric oxide synthase and the production of Nitric oxide radicals Human Plasma K3EDTA Colourimetric Microplate Reader 5 µM 35 µM
    2 Nitrite Marker For the Activity of Nitric oxide synthase and the production of Nitric oxide radicals Human Plasma K3EDTA Colourimetric Microplate Reader 0.0004 0.20
    3 Anti X LMWH therapy is monitored by the ratio of anti-factor Xa and Anti Factor IIa assay, The amount of residual factor Xa or Factor IIa is inversely proportional to the amount of heparin/LMWH in the plasma Human Plasma Na-Citrate Chromogenic Microplate Reader 0.1 IU/mL 1 IU/mL
    4 Anti IIa LMWH therapy is monitored by the ratio of anti-factor Xa and Anti Factor IIa assay, The amount of residual factor Xa or Factor IIa is inversely proportional to the amount of heparin/LMWH in the plasma Human Plasma Na-Citrate Chromogenic Microplate Reader 0.05 IU/mL 0.2 IU/mL
    5 TFPI Extrinsic Pathway- Tissue Factor Pathway Inhibitor, For Determination of heparin Presence. Human Plasma CTAD ELISA- Colorimetric Microplate Reader 31.25 pg/mL 2.0 ng/mL
    6 C-Peptide NA Human Serum NA ELISA Microplate Reader 28.89 pM 850 pM
    7 C-Peptide (Human) NA Human Serum NA ECLIA Cobas e411 40 pmol/L 4000 pmol/L
    8 G-CSF Febrile Neutropenia Human Serum NA ELISA Microplate Reade 2.014 50.0
    9 Heparin Clotting Assay To determine the clotting time difference in presence of LMWH Human Plasma CTAD Clotting Assay Coagulation Analyzer 0.15 IU/mL 1.0 IU/mL
    10 IgG Immunoglobulin- IgG, specific Heparin antibody qualitative detection for immunogenicity of LMWH Human Serum NA Qualitative-ELISA Method Microplate Reader NA NA
    11 IgA Immunoglobulin- IgA, specific Heparin antibody qualitative detection for immunogenicity of LMWH Human Serum NA Qualitative-ELISA Method Microplate Reader NA NA
    12 IgM Immunoglobulin- IgM, specific Heparin antibody qualitative detection for immunogenicity of LMWH Human Serum NA Qualitative-ELISA Method Microplate Reader NA NA
    13 IgGAM Immunoglobulin- IgG, IgM and IgA, specific Heparin antibodies qualitative detection for immunogenicity of LMWH Human Serum NA Qualitative-ELISA Method Microplate Reader NA NA
    14 Insulin Human Antidiabetic Human Serum NA ECLIA Cobas e411 10 pmol/L 2500 pmol/L
    15 Insulin Aspart Antidiabetic Human Serum NA ELISA Microplate Reader SYNERGY H1 15.714 pM 500 pM
    16 Insulin Aspart Antidiabetic Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.100 5.00
    17 A-H-PF4 Anti Heparin Platlate factor Human Plasma CTAD ELISA- Colorimetric Microplate Reader NA NA
    18 Total Iron For Estimation of total Iron after Iron sucrose therepy Human Serum K3EDTA LC/MS/MS API 3000 2.0 1000
    19 Teriperatide (PTH) Osteoporosis Human Plasma K3EDTA ELISA Microplate Reader 0.015 0.20
    20 Transferrin bound Iron(TBI) For Estimation of transferrin bound Iron after Iron sucrose therapy Human Serum NA Colorimetric Microplate Reader 200 ng/mL 8000 ng/mL
  • Validated Methods for New Chemical Entities
    Sr. No. In-House ID Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    1 VIN-NCE-001 PL-1 Human Plasma Na Heparin LC/MS/MS API 4000 0.5 500
    2 VIN-NCE-001 UR-1 Human Urine NA LC/MS/MS API 4000 5.0 5000
    3 VIN-NCE-002 PL Human Plasma Na Heparin LC/MS/MS API 4000 10.0 2000
    4 VIN-NCE-003 P Human Plasma Na Heparin LC/MS/MS API 4000 20.0 5000
    5 VIN-NCE-004 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 150
    6 VIN-NCE-005 PL Human Plasma Na Heparin LC/MS/MS API 4000 0.50 100
    7 VIN-NCE-006 PL Human Plasma Na Heparin LC/MS/MS API 3000 1.00 1000
    8 VIN-NCE-007 PL Human Plasma Na Heparin LC/MS/MS API 3000 5.00 5000
    9 VIN-NCE-008 PL Human Plasma K2 EDTA LC/MS/MS API 4000 0.10 100
    10 VIN-NCE-008 UR Human Urine NA LC/MS/MS API 4000 1.00 1000
    11 VIN-NCE-009 PL Human Plasma Na Heparin LC/MS/MS API 4000 0.10 100
    12 VIN-NCE-009 UR Human Urine NA LC/MS/MS API 4000 1.00 1000
    13 VIN-NCE-010 PL Human Plasma K3 EDTA LC/MS/MS API 3000 5.00 5000
    14 VIN-NCE-011 PL Human Plasma Na Heparin LC/MS/MS API 3000 5.00 5000
    15 VIN-NCE-012 PL Human Plasma Na Heparin LC/MS/MS API 3000 0.50 500
    16 VIN-NCE-014 PL Human Plasma Na Heparin LC/MS/MS Premier XE 25.0 1000
    17 VIN-NCE-013 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 500
    18 VIN-NCE-012 PL Human Plasma Na Heparin LC/MS/MS API 3000 1.00 500
    19 VIN-NCE-016 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.10 100
    20 VIN-NCE-017 BL Human Blood Na Heparin LC/MS/MS Premier XE 0.50 100
  • Validated Methods for New Chemical Entities
    Sr. No. In-House ID Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    21 VIN-NCE-018 BL Human Blood Na Heparin LC/MS/MS API 3000 3.0 1200
    22 VIN-NCE-019 PL Human Urine EDTA LC/MS/MS API 2000 10.0 250
    23 VIN-NCE-020 PL Human Plasma Na Heparin LC/MS/MS API 2000 1.00 25.0
    24 VIN-NCE-021 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.030 100
    25 VIN-NCE-022 SK Human Skin Na Heparin LC/MS/MS API 3000 12.0 9000
    26 VIN-NCE-023 PL Human Plasma Na Heparin LC/MS/MS API 3000 3.00 2400
    27 VIN-NCE-024 PL Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 1000
    28 VIN-NCE-025 UR Human Urine Na Heparin LC/MS/MS Premier XE 0.50 1000
    29 VIN-NCE-026 PL Human Blood EDTA LC/MS/MS API 3000 0.30 200
    30 VIN-NCE-027 PL Human Urine EDTA LC/MS/MS API 4000 2.00 1000
    31 VIN-NCE-028 PL Human Plasma EDTA LC/MS/MS Premier XE 5.00 3000
    32 VIN-NCE-029 PL Human Urine Na Heparin LC/MS/MS Premier XE 2.00 2500
    33 VIN-NCE-030 TI Colon tissue NA LC/MS/MS API 3000 12.0 9000
    34 VIN-NCE-022 CT Colon tissue NA LC/MS/MS API 3000 12.0 9000
    35 VIN-NCE-012 PL Human Plasma K2EDTA LC/MS/MS API 4000 0.500 5000
    36 VIN-NCE-032 PL Human Plasma K2EDTA LC/MS/MS API 5500 0.050 50.0
    37 VIN-NCE-034 PL Human Plasma K2EDTA LC/MS/MS API 4000 0.005 5.50
    38 VIN-NCE-038 UR Human Urine NA LC/MS/MS API 3200 1.00 1000
    39 VIN-NCE-037 UR Human Urine NA LC/MS/MS API 3200 0.10 10000
    40 VIN-NCE-035 PL Human Plasma K2EDTA LC/MS/MS API 3200 5.0 5000
  • Validated Methods for New Chemical Entities
    Sr. No. In-House ID Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    41 VIN-NCE-041 PL Human Plasma K2EDTA LC/MS/MS LCMS-8050 1.00 2000
    42 VIN-NCE-039PL Human Urine K2EDTA LC/MS/MS LCMS-8060 1.00 1000
    43 VIN-NCE-043 PL Human Plasma K2EDTA LC/MS/MS API 4000 2.0 1000
    44 VIN-NCE-037UR Human Urine NA LC/MS/MS API 3200 10.00 10000
    45 VIN-NCE-042PL Human Plasma K2EDTA LC/MS/MS LCMS-8050 0.02 10
    46 VIN-NCE-044PL (Drug + Metabolite) Human Plasma K3EDTA LC/MS/MS Premier XE 1.00
    1.00    		 1000
    1000
    47 VIN-NCE-040PL Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 1000
    48 VIN-NCE-045PL Human Urine K3EDTA LC/MS/MS LCMS-8050 0.50 2000
    49 VIN-NCE-046PL (Drug + Metabolite) Human Blood K3EDTA LC/MS/MS API 4000 5.00
    1.00     		5000
    1000
    50 VIN-NCE-047UR Human Urine NA LC/MS/MS API 4000 1.00 2000
    51 VIN-NCE-048PL Human Plasma K3EDTA LC/MS/MS API 3200 1.0 5000
    52 VIN-NCE-049PL (Drug + Metabolite) NCE Human Plasma K3EDTA LC/MS/MS 0.005
    0.20    		 5.00
    20.0
    53 VIN-NCE-050PL NCE Human Plasma K2EDTA LC/MS/MS 1.0 5000
    54 VIN-NCE-51PL NCE Human Plasma K2EDTA LC/MS/MS 0.50
    0.50    		 1000
    1000
    55 VIN-NCE-52PL NCE Human Plasma K2EDTA LC/MS/MS 0.0 50
    56 VIN-NCE-53UR NCE Human Urine NA LC/MS/MS 10.0 50
    57 VIN-NCE-54PL NCE Human Plasma K2EDTA LC/MS/MS 50.0 20000
    58 VIN-NCE-55PL NCE Human Plasma K3EDTA HPLC-UV 300µg/mL 5000µg/mL
    59 VIN-NCE-56PL NCE Human Plasma K3EDTA LC/MS/MS 0.0 20
    60 VIN-NCE-57PL NCE Human Plasma K3EDTA LC/MS/MS 1.0 1000
  • Validated Methods for New Chemical Entities
    Sr. No. In-House ID Matrix Anti-Coagulant Method Equipment LLOQ (ng/mL) ULOQ (ng/mL)
    61 VIN-NCE-58PL NCE Human Plasma K2EDTA LC/MS/MS 1.00 10000
    62 VIN-NCE-59PL NCE Human Plasma K3EDTA LC/MS/MS 2.0 1000
    63 VIN-NCE-60PL NCE Na Heparin Na Heparin LC/MS/MS 2.0 2500
    64 VIN-NCE-61PL NCE Human Plasma K2EDTA LC/MS/MS 0.5 1500
    65 VIN-NCE-62UR NCE Human Urine NA LC/MS/MS 2.0 4000
    66 VIN-NCE-63PL NCE Human Plasma K2EDTA LC/MS/MS 0.0 20
  • Methods Under Development / Validation
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    1 20 Amino Acid (UR) Amino acids Human Urine NA LC/MS/MS LCMS-8040 38.0 60000.0
    2 Amlodipine + Valsartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 0.025
    20.0    		 15.0
    12000
    3 Buspirone Anxiolytic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 500
    4 Carbamazepine Antiepileptic Human Plasma K3EDTA LC/MS/MS API 2000 20.00 10000
    5 Cariprazine Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10 50.0
    6 Clozapine Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.40 100
    7 Diazepam benzodiazepines Human Plasma K3EDTA LC/MS/MS API 4000 1.00 800
    8 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.050 40.0
    9 Dimenhydrinate Antihistamine Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200
    10 Fluvoxamine Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.40 400
    11 Fluticasone Propionate (In presence of Salmeterol) Corticosteroid, Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.002 500
    12 Ibuprofen + Paracetamol anti-inflammatory & antipyretics Human Plasma K3EDTA LC/MS/MS API 3200 100.00
    30.00    		 30000.0
    9000.0
    13 Insulin Glargine +
    Metabolite M1 +
    Metabolite M2    		 Antidiabetic Human Plasma K2EDTA LC/MS/MS LCMS-8060 0.10
    0.10
    0.10    		 5.00
    5.00
    5.00
    14 Lapatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 3200 10.0 8000
    15 Mirabegron Urinary incontinence Human Plasma Na Heparin LC/MS/MS API 5500 0.10 80.0
    16 Midostaurin Antineoplastic agents Human Plasma K3EDTA LC/MS/MS LCMS-8050 5.00 2500.0
    17 N-Acetyl -L-Cysteine (UR) Amino acids Human Urine NA LC/MS/MS LCMS-8040 20.00 4000.0
    18 Norethisterone (Norethindrone) Progestogen Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.050 20.0
    19 Perindropril + Perindoprilat Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00
    0.20    		 300
    60.0
    20 Pazopanib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 300 150000
  • Methods Under Development / Validation
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    21 Progesterone Progestogen Human Plasma K3EDTA LC/MS/MS API 5500 0.10 100
    22 Propranolol & 4- Hydroxy Propranolol Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040 1.00
    0.50    		 500
    250
    23 Saxagliptin + 5-Hydroxy Saxagliptin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000 0.20
    0.40    		 100
    200
    24 Tiotropium bronchodilators Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.0001 0.050
    25 Transferrien Bound Iron (TBI) Iron Defficiency Anaemia Human serum NA ICP OES Optima 8000 400 50000
    26 Total Iron (TOI) Iron Defficiency Anaemia Human serum NA ICP OES Optima 8000 400 800000
    27 Verapamil + Norverapamil Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50
    0.50    		 250
    250
    28 Vigabatrin Antiepileptic Human Plasma K3EDTA LC/MS/MS API 4000 500 300000
    29 Zileuton Asthma Human Plasma K3EDTA LC/MS/MS API 3200 20.0 10000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    1 Abacavir Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 30.0 7500
    2 Abacavir Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 30.000 9000.0
    3 Abacavir + Lamivudine Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 24.0
    60.0    		 6000
    15000
    4 Abiraterone Metastatic prostate cancer Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.500 200.0
    5 Abiraterone Metastatic prostate cancer Human Plasma K3EDTA LC/MS/MS LCMS-8050 5.00 2000
    6 Abiraterone Metastatic prostate cancer Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.400 500.0
    7 Acetaminophen (Paracetamol) Antipyretic, Analgesic Human Plasma K3EDTA LC/MS/MS API 3000 300.00 20000
    8 Acetaminophen (Paracetamol) Antipyretic, Analgesic Human Plasma K3EDTA LC/MS/MS API 3000 200.000 20000.0
    9 Acetazolamide Carbonic anhydrase inhibitor, diuretic Human Plasma K3EDTA LC/MS/MS API 2000 20.0 20000
    10 Acetazolamide Carbonic anhydrase inhibitor, diuretic Human Plasma K3EDTA LC/MS/MS API 2000 10.000 5000.0
    11 Acetazolamide Carbonic anhydrase inhibitor, diuretic Human Plasma K3EDTA LC/MS/MS API 2000 30.00 18000
    12 Acetazolamide Carbonic anhydrase inhibitor, diuretic Human Plasma K3EDTA LC/MS/MS LCMS - 8050 60.000 30000.0
    13 Acitretin Psoriasis Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.20 300
    14 Acitretin+ 13 - Cis Acitretin Psoriasis Human Plasma K3EDTA LC/MS/MS API 4000 5.00 500
    15 Acyclovir Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 5.00 2500
    16 Afatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200
    17 Agomelatine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.005 10.0
    18 Agomelatine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.005 50.0
    19 Alfuzosin Benign prostatic hyperplasia Human Plasma K3EDTA LC/MS/MS API 4000 0.050 30.0
    20 Alfuzosin Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.40 80
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    21 Alimemazine Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.020 10.0
    22 Aliskiren Renin inhibitor Human Plasma K3EDTA LC/MS/MS API 3000 0.30 300
    23 Alogliptin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 0.80 400
    24 Alosetron 5-HT3 Antagonist Human Plasma K3EDTA LC/MS/MS API 4000 0.05 20
    25 Alprazolam Anxiolytic Human Plasma Na Heparin LC/MS/MS Premier XE 0.20 40
    26 Allopurinol Anti gout Human Plasma K3EDTA LC/MS/MS LCMS-8050 15.0 9000
    27 Alverine + 4-Hydroxy Alverine Smooth muscle relaxant Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.01
    0.05    		 3.00
    15.0
    28 Aminocaproic acid Bleeding Disorders Human Plasma K3EDTA LC/MS/MS API 3200 500 100000
    29 Amisulpride Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 5.00 2500
    30 Amlodipine + Valsartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.10
    100    		 10.0
    10000
    31 Amlodipine + Valsartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.10
    40.0    		 12.0
    4800
    32 Albendazole + Albendazole Sulfoxide Anthelmintic Human Plasma K3EDTA LC/MS/MS API 4000 0.20
    4.00    		 100
    2000
    33 Amantadine Antiviral and an Antiparkinsonian drug Human Plasma K3EDTA LC/MS/MS API 2000 2.00 1000
    34 Ambroxol + Gauifenesin Expectorant Human Plasma K3EDTA LC/MS/MS API 4000 0.40
    5.00    		 200
    2500
    35 Amiodarone Antiarrhythmic Human Plasma K3EDTA LC/MS/MS API 4000 2.00 1000
    36 Amitriptyline+ Nortriptyline Antidepressant Human Plasma K3EDTA LC/MS/MS Premier XE 0.20
    0.08    		 120
    48.0
    37 Amitriptyline+ Nortriptyline Antidepressant Human Plasma K3EDTA LC/MS/MS Premier XE 0.20
    0.09    		 120
    48.1
    38 Amitriptyline+ Nortriptyline Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20
    0.050    		 80.0
    20.0
    39 Amlodipine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.03 10.0
    40 Amlodipine + Celecoxib Antihypertensive / NSAID Human Plasma K3EDTA LC/MS/MS API 4000 0.10
    10.0    		 25.0
    2500
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    41 Amlodipine +
    HCTZ +
    Olmesartan    		 Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.05
    1.00
    10.0    		 15.0
    300
    3000
    42 Amlodipine + Olmesartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.040
    10.0    		 12.0
    3000
    43 Amlodipine + Telmisartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.05
    5.00    		 10.0
    1000
    44 Amlodipine + Valsartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.10
    40.0    		 12.0
    4800
    45 S-Amlodipine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.03 2.0
    46 S-Amlodipine+ Hydrochlorothiazide Antihypertensive Human Plasma K3EDTA LC/MS/MS API4000 0.03
    1.00     		12.0
    400
    47 S-Amlodipine + Hydrochlorothiazide Antihypertensive Human Plasma K3EDTA LC/MS/MS API4000 0.03
    1.00    		 12.0
    400
    48 Amoxicillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 160 30000
    49 Amoxicillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 200 30000
    50 Amoxicillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 50.0 25000
    51 Anastrozole Anticancer Human Plasma K3EDTA LC/MS/MS API 3000 0.20 60
    52 Apixaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS API 2000 1.00 400
    53 Apremilast Psoriatic Arthritis Human Plasma K3EDTA LC/MS/MS Premier XE 4.00 800
    54 Aprepitant Antiemetic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 4000
    55 Aprepitant Antiemetic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 8000
    56 Aripriprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.50 400
    57 Aripiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.50 200
    58 Aripiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 2.00 800
    59 Aripriprazole + Escitalopram Antipsychotic, Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.25
    0.10    		 65.0
    24.0
    60 Armodafinil Wakefulness promoting agent Human Plasma K3EDTA LC/MS/MS API 3000 50 15000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    61 Artemether+ Dihydroartimisnin Antimalarial Human Plasma Na Heparin LC/MS/MS API 4000 3.00 360
    62 Artimether + Dihydroartemisinin Antimalarial Human Plasma K3EDTA LC/MS/MS API 4000 0.50
    0.50    		 300
    300
    63 Artesunate + Dihydroartemisinin Antimalarial Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.800
    0.800    		 500
    500
    64 Asenapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.10 20.0
    65 Asenapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 20.0
    66 Aspirin + Salicylic Acid Analgesic Human Plasma Na Heparin LC/MS/MS API 2000 2000.00 80000
    67 Aspirin + Salicylic acid Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 4.0
    100    		 2000
    7000
    68 Aspirin(Sensitive) Analgesic Human Plasma K3EDTA LC/MS/MS Premier XE 10.00 2000
    69 Atazanavir Antiviral Human Plasma K3EDTA LC/MS/MS API 3200 30.0 15000
    70 Atazanavir Antiviral Human Plasma K3EDTA LC/MS/MS LCMS - 8050 20.0 8000
    71 Atenolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 8.00 2200
    72 Atenolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 10.0 1500
    73 Atomoxetine Hyperactivity disorder (ADHD) Human Plasma K3EDTA LC/MS/MS API 4000 5.00 2000
    74 Atorvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 200
    75 Atorvastatin Antihyperlipidemic Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.50 300
    76 Atorvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.25 400
    77 Atorvastatin +
    2 - Hydroxy Atorvastatin+
    4 - Hydroxy Atorvastatin    		 Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 3000 0.25
    0.50
    0.50    		 50
    100
    100
    78 Atorvastatin +
    2 - Hydroxy Atorvastatin+
    4 - Hydroxy Atorvastatin    		 Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.10
    0.10
    0.05    		 100
    100
    50
    79 Atorvastatin+
    2 - Hydroxy Atorvastatin+
    4 - Hydroxy Atorvastatin    		 Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.2
    0.2
    0.1    		 200
    200
    100
    80 Atorvastatin +
    2- Hydroxy Atorvastatin +
    4- Hydroxy Atorvastatin    		 Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.020
    0.020
    0.010    		 20.0
    20.0
    10.0
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    81 Atorvastatin +
    2 - Hydroxy Atorvastatin+
    4 - Hydroxy Atorvastatin+
    Glimpride    		 Antihyperlipidemic Antidiabetic Human Plasma Na Heparin LC/MS/MS API 4000 0.1
    0.1
    0.05
    0.50    		 40
    40
    20
    200
    82 Atorvastatin + 2 - Hydroxy Atorvastatin+ 4 - Hydroxy Atorvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.32
    0.224
    0.048    		 200
    140
    30.0
    83 Atovaquone Antiprotozoal Human Plasma K3EDTA LC/MS/MS API 3000 100.00 20000
    84 Axitinib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 0.200 100
    85 Axitinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.075 100
    86 Axitinib Anticancer Human Plasma K3EDTA LC/MS/MS Waters QPXE 0.250 150
    87 Azilsartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 30.000 15000.0
    88 Azilsartan + Chlorthalidone Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040 10.0
    2.00    		 5000
    1000
    89 Azithromycin Antibiotics Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000
    90 Azithromycin Antibiotic Human Plasma K3EDTA LC/MS/MS API3000 5.00 2000
    91 Azythromycin Antibiotic Human Plasma K3EDTA LC/MS/MS API 3000 1.00 400
    92 Azithromycin Antibiotics Human Plasma K3EDTA LC/MS/MS API 3000 1.00 700
    93 Baclofen Muscle relaxant and antispastic Human Plasma K3EDTA LC/MS/MS API 4000 5.00 1000
    94 Baclofen Muscle relaxant and antispastic Human Plasma K3EDTA LC/MS/MS API 4000 3.00 2400
    95 Barnidipine Antihypertensive Human Plasma CPDA, EDTA LC/MS/MS API 3000 0.02 10
    96 Barnidipine Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS - 8050 0.004 8.00
    97 Benazepril + Benazeprilat Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 1.00
    2.00    		 400 800
    98 Bendroflumethiazide Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 200
    99 Benzonatate + 4-Butylamino Benzoic Acid Symptomatic relief of cough Human Plasma K3EDTA LC/MS/MS LCMS - 8050 0.050
    3.00    		 100
    6000
    100 Bexarotene Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    101 Bilastine Antihistamine Human Plasma Na Heparin LC/MS/MS LCMS-8050 2.00 600
    102 Binimetinib anti-cancer Human Plasma Li-Heparine LC/MS/MS LCMS-8050 1.00 500
    103 Bisoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 2000 0.50 100
    104 Bisoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20 150
    105 Bisoprolol + Hydrochlorothiazide Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50
    0.50    		 100
    100
    106 Bortezomib Anticancer Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 1400
    107 Bortezomib Anticancer Human Plasma Na Heparin LC/MS/MS LCMS-8040 0.225 50.0
    108 Bortezomib Anticancer Human Plasma Na Heparin LC/MS/MS LCMS-8040 0.225 50.0
    109 Bosentan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 50.00 5000
    110 Bosentan(Sensitive ) Endothelin receptor antagonis Human Plasma K3EDTA LC/MS/MS API 4000 20.00 5000
    111 Bosentan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 10.0 5000
    112 Bosutinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.20 120
    113 Brexpiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 60.0
    114 Brexpiprazole Antipsychotic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 150
    115 Budesonide Glucocorticoid Human Plasma CPDA, EDTA LC/MS/MS LCMS-8050 0.010 4.50
    116 Budesonide Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.015 4.50
    117 Budesonide Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.010 8.00
    118 Bumetanide Diuretic Human Plasma K3EDTA LC/MS/MS API 3200 1.00 200
    119 Bupivacaine Local Anesthetic Human Plasma K3EDTA LC/MS/MS Premiere XE 5.00 2500
    120 Bupivacaine Local Anesthetic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 500
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    121 Bupropion + Hydroxy Bupropion Antidepressant Human Plasma Na Heparin LC/MS/MS API 3000 1.50 300
    122 Buspiron Anxiolytic Human Plasma Li-Heparine LC/MS/MS API 3000 0.05 5.00
    123 Butylscopolamine (Butylhyoscine) Abdominal pain Human Plasma K3EDTA LC/MS/MS API 5500 0.002 0.25
    124 Butylscopolamine (Butylhyoscine) Abdominal pain Human Plasma K3EDTA LC/MS/MS API 5500 0.002 800
    125 Cabergoline Dopamine receptor agonist Human Plasma K3EDTA LC/MS/MS API 5500 0.0015 0.100
    126 Cabergoline Dopamine receptor agonist Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.0015 0.100
    127 Cabozanitinib Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 2.00 1000
    128 Canagliflozin Antidiabetic Human Plasma Na Heparin LC/MS/MS API 4000 10.0 6000
    129 Canagliflozin + Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000 5.00
    5.00    		 3000
    3000
    130 Candesartan Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 1.00 500
    131 Candesartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 2.00 700
    132 Candesartan + Hydrochlorothiazide Antihypertensive Diuretic Human Plasma K3EDTA LC/MS/MS API 3000 2.0
    1.0    		 1000
    500
    133 Capecitabine Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 10.00 10000
    134 Captopril Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 5.00 1000
    135 Carbamazepine Antiepileptic Human Plasma CPDA, EDTA LC/MS/MS API 2000 20.00 5000
    136 Carbamazepine Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 20.00 10000
    137 Carbamazepine Antiepileptic Human Plasma K3EDTA LC/MS/MS API 3200 10.0 3000
    138 Carbidopa+ Levodopa Parkinson's disease Human Plasma K3EDTA LC/MS/MS Premier XE 2.00
    20.0    		 400
    4000
    139 Carbidopa + Levodopa Parkinson's disease Human Plasma K3EDTA LC/MS/MS API 5500 0.25
    20.0    		 150
    4000
    140 Carvedilo + 4-Hydroxyphenyl Carvedilol Beta–blocker Human Plasma K3EDTA LC/MS/MS Premier XE 0.5
    0.150    		 100
    30.0
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    141 Carglumic Acid Carbamoyl Phosphate Synthetase 1 activator Human Plasma Na Heparin LC/MS/MS API 4000 50.0 10000
    142 Cefaclor Antibacterial Human Plasma CPDA, EDTA LC/MS/MS HPLC-UV 500 50000
    143 Cefaclor Antibiotic Human Plasma K3EDTA LC/MS/MS API 2000 200 20000
    144 Cefadroxil Antibiotic Human Plasma CPDA, EDTA LC/MS/MS API 2000 300 60000
    145 Cefadroxil Antibiotic Human Plasma K3EDTA LC/MS/MS API 2000 200 40000
    146 Cefditoren Antibiotic Human Plasma K3EDTA LC/MS/MS Premier XE 25.0 5000
    147 Cefixime Antibacterial Human Plasma EDTA HPLC-UV HPLC-UV 100 20000
    148 Cefixime Cephalosporin Antibiotic Human Plasma Na Heparin LC/MS/MS API 4000 25.00 15000
    149 Cefixime Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 100 20000
    150 Cefpodoxime acid Antibacterial Human Plasma EDTA LC/MS/MS API 2000 20.0 3000
    151 Cefpodoxime acid Antibacterial Human Plasma K3EDTA HPLC-UV HPLC-UV 200 10000
    152 Cefuroxime acid Antibacterial Human Plasma EDTA HPLC-UV HPLC-UV 150 30000
    153 Cefuroxime acid Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 75.0 1500
    154 Cefuroxime Antibacterial Human Plasma K3EDTA LC/MS/MS API 3200 60.0 12000
    155 Celecoxib NSAID Human Plasma CPDA, EDTA LC/MS/MS API 4000 20.00 5000
    156 Celecoxib NSAID Human Plasma K3EDTA LC/MS/MS API 4000 5.00 2500
    157 Cephalexin Antibacterial Human Plasma EDTA HPLC HPLC-UV 200 120000
    158 Cephalexin Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000 500 50000
    159 Cephalexin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3200 50.0 25000
    160 Cetirizine Non-sedative Antihistamine Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    161 Chlorpheniramine + Phenylephrine Antihistamine Decongestant Human Plasma Na Heparin LC/MS/MS API 4000 0.10
    0.05     		20.0
    10.0
    162 Chlorpromazine + 7-Hydroxy Chlorpromazine Antipsychotic Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.50
    0.20    		 250
    100
    163 Chlorpromazine + 7-Hydroxy Chlorpromazine Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.020
    0.020    		 20.0
    20.0
    164 Chlorthalidone Diruretic Human Plasma CPDA, EDTA LC/MS/MS LC 8040 20.0 8000
    165 Chlorthalidone Diruretic Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 1000
    166 Chlorthalidone + Telmisartan Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00
    2.00    		 250
    500
    167 Chlorzoxazone Muscle relaxant Human Plasma K3EDTA LC/MS/MS LCMS-8050 50.0 20000
    168 Chlorzoxazone Muscle relaxant Human Plasma Na Heparin LC/MS/MS API 3200 200 80000
    169 Cinnargine Antihistamine Human Plasma EDTA LC/MS/MS Premier XE 5.00 750
    170 Ciprofloxacin Antibacterial Human Plasma EDTA LC/MS/MS API 2000 100 10000
    171 Clarithromycin Antibacterial Human Plasma EDTA LC/MS/MS API 3000 50.0 10000
    172 Clarithromycin + 14(R)-hydroxy-Clarithromycin Antibacterial Human Plasma EDTA LC/MS/MS API 3000 40.0
    15.0    		 8000
    3000
    173 Clarithromycin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 10.0 5000
    174 Clindamycin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3200 10.0 8000
    175 Clobazam + N-Desmethyl Clobazam Antiepileptic Human Plasma CPDA, EDTA LC/MS/MS Premier XE 5.00
    1.00    		 1500 300
    176 Clomipramine + Desmethyl Clomipramine Antidepressant Human Plasma K3EDTA LC/MS/MS API 3000 1.00
    1.00     		300
    300
    177 Clomipramine + Desmethyl Clomipramine Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20
    0.80    		 50.0
    200
    178 Clomipramine + Desmethylclomipramine Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10
    0.050    		 6.0
    30.0
    179 Clonazepam Antiepileptic Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 30.0
    180 Clonazepam Antiepileptic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.050 20.0
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    181 Clonidine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.025 2.50
    182 Clonidine Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.003 1.50
    183 Clopidogre Anti–platelet Human Plasma CPDA, EDTA LC/MS/MS API 2000 0.20 25.0
    184 Clopidogrel Anti–platelet Human Plasma K3EDTA LC/MS/MS API 4000 0.050 10.0
    185 Clopidogrel Anti–platelet Human Plasma K3EDTA LC/MS/MS API 5500 0.005 5.00
    186 Clopidogrel Anti–platelet Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.010 10.0
    187 Clopidogrel+ Clopidogrel Carboxylic acid Anti–platelet Human Plasma K3EDTA LC/MS/MS API 4000 0.05 50.0 10.0 10000
    188 Clopidogrel Carboxylic acid NA Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 10000
    189 Clozapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 10.0 1000
    190 Cyclobenzaprine Muscle spasm Human Plasma K3EDTA LC/MS/MS API 4000 0.050 20.0
    191 Cyclosporin (Ciclosporin) Immunosuppressant Human Blood K3EDTA LC/MS/MS Premier XE 5.00 2000
    192 Dabigatran (free) Thrombin Inhibitor Human Plasma Na-Citrate LC/MS/MS API 4000 1.00 300
    193 Dalfampridine Multiple sclerosis Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.40 100
    194 Dapagliflozine Antidiabetic Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 500
    195 Dapsone Antileprotic Human Plasma CPDA, EDTA LC/MS/MS API 4000 25.0 5000
    196 Dapsone + N-Acetyl Dapsone Antileprotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.045
    0.015     		18.0
    6.00
    197 S-Dapoxetine Selective serotonin reuptake inhibitor Human Plasma EDTA LC/MS/MS API 4000 1.00 1000
    198 Dapoxetine + Tadalafil Erectile dysfunction Human Plasma K3EDTA LC/MS/MS LCMS-8050 2.00
    2.00    		 800
    800
    199 Darifenacin Urinary incontinence Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025 5.00
    200 Darifenacin Urinary incontinence Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025 12.0
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    201 Darunavir Antiretroviral Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 20000
    202 Darunavir Antiretroviral Human Plasma K3EDTA LC/MS/MS Premiere XE 50.0 20000
    203 Dasatinib Anticancer Human Plasma CPDA, EDTA LC/MS/MS API 2000 1.00 400
    204 Dasatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 1.00 400
    205 Deferasirox Iron Chelator Human Plasma K3EDTA LC/MS/MS API 2000 100 60000
    206 Deferasirox Iron Chelator Human Plasma K3EDTA LC/MS/MS LCMS-8050 100 60000
    207 Deferiprone + Deferiprone Glucuronide Iron Chelator Human Plasma Na Heparin LC/MS/MS API 2000 250
    125    		 40000
    20000
    208 Desipramine Antidepressant Human Plasma K3EDTA LC/MS/MS API4000 0.50 150
    209 Desipramine + 2-Hydroxy Desipramine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.5
    0.15    		 150
    45
    210 Desloratadine Antihistamine Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.20 10.0
    211 Desloratadine + 3-Hydroxy Desloratidine Antihistamine Human Plasma K3EDTA LC/MS/MS API 4000 0.05 10.0
    212 Desloratidine + 3-Hydroxy Desloratidine Antihistamine Human Plasma EDTA LC/MS/MS API 4000 0.05 10.0
    213 Desloratidine + 3-Hydroxy desloratidine Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025
    0.025    		 7.50
    7.50
    214 Desmopressin Synthetic replacement of vasopressin harmone Human Plasma K3EDTA LC/MS/MS APi 5500 0.002 0.250
    215 Desvenlafaxine Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 2.00 700
    216 Dexamethasone Corticosteroid Human Plasma K3EDTA LC/MS/MS Premier XE 2.00 600
    217 Dexamethasone Corticosteroid Human Plasma EDTA LC/MS/MS API 4000 0.25 100
    218 Dexamethasone Corticosteroid Human Plasma K3EDTA LC/MS/MS API 4000 0.50 150
    219 Dexlansoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 5.00 2500
    220 Dextromethorphan + Dextrorphan Cough Suppressant Human Plasma K3EDTA LC/MS/MS API 3000 0.10
    10.0    		 20.0
    2000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    221 Dextromethorphan+ Dextrorphan Cough Suppressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.030
    0.030    		 15.0
    5.0
    222 Dextromethorphan + Guanafenesin Cough Suppressant Expectorant Human Plasma K3EDTA LC/MS/MS API 3000 0.10
    25.0    		 20.0
    5000
    223 Diacerein + Rhein Osteoarthritis Human Plasma CPDA, EDTA LC/MS/MS LCMS-8050 15.0
    15.0    		 6000
    6000
    224 Diazoxide Hyperinsulinism Human Plasma K3EDTA LC/MS/MS API 4000 30.0 12000
    225 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 3000 25.0 4000
    226 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8040 10.0 4000
    227 Diclofenac Analgesic Human Plasma Na Heparin LC/MS/MS API 2000 50.0 15000
    228 Dilclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 2.00 4000
    229 Diclofenac Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 40.0 40000
    230 Diclofenac + Esomeprazole Analgesic Proton pump inhibitor Human Plasma CPDA, EDTA LC/MS/MS API 4000 8.00
    4.00    		 4000
    2000
    231 Dicloxacillin Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000 200 80000
    232 Dicyclomine (Dicycloverine) Antispasmodic Human Plasma EDTA LC/MS/MS LCMS-8040 0.50 120
    233 Dihydroartemisinin Anitmalerial Human Plasma K3EDTA LC/MS/MS API 4000 2.00 1000
    234 Dihydrotetrabenazine Huntington's disease Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 200
    235 Diltiazem + N-Desmethyl Diltiazem + Desacetyl Diltiazem Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 1.5
    0.5
    0.5    		 450
    150
    150
    236 Diltiazem +
    N-Desmethyl diltiazem +
    Desacetyl diltazem     		Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040 4.00
    1.00
    0.50    		 1200
    300
    150
    237 Diphendydramine + Naproxen Antihistamine NSAID Human Plasma EDTA LC/MS/MS API 4000 0.50
    500    		 150
    150000
    238 Dipyridamole Vasodilator Human Plasma K3EDTA LC/MS/MS API 2000 5.00 4500
    239 Dipyridamole Vasodilator Human Plasma K3EDTA LC/MS/MS API 2000 5.00 5000
    240 Disulfiram Metabolite 2 For Chronic Alcoholism (Disulfiram) Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 250
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    241 Disulfiram Primary Metabolite NA (Inactive Metabolite of Disulfiram) Human Plasma K3EDTA HPLC-UV Shimadzu LC20 2.00 200
    242 Docetaxel(Total) Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 10.0 6000
    243 Dofetilide Antiarrhythmic Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.010 5.00
    244 Dolutegravir Antiviral Human Plasma K3EDTA LC/MS/MS API 5500 20.0 8000
    245 Doltegravir +
    Emtricitabine+
    Tenofovir Alafenamide    		 Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8040 30.0
    20.0
    2.00    		 7500
    5000
    500
    246 Donepezil Alzheimer Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 200
    247 Donepezil Alzheimer Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.20 50.0
    248 Donepezil + Memantine Alzheimer Human Plasma K3EDTA LC/MS/MS API 4000 0.50
    0.50    		 200
    200
    249 Donepezil + Memantine Alzheimer Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.20
    0.30    		 60.0
    90.0
    250 Dosulepin Antidepressant Human Plasma CPDA, EDTA LC/MS/MS LCMS-8040 0.20 120
    251 Doxazosin Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20 50.0
    252 Doxepin + Nordoxepin Antidepressant Human Plasma EDTA LC/MS/MS LCMS-8040 0.20
    0.050    		 80.0
    20.0
    253 Doxepin + Nordoxepin Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.005
    0.005    		 10.0
    10.0
    254 Doxepin + Nordoxepin Alzheimer Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.20
    0.050    		 160
    40.0
    255 Doxorubicin (Total) Anticancer Human Plasma K3EDTA LC/MS/MS API 3000 150 60000
    256 Doxycycline Antibacterial Human Plasma Na HeparinA LC/MS/MS Premier XE 10.0 5000
    257 Doxycycline Antibacterial Human Plasma EDTA LC/MS/MS Premier XE 10.0 1500
    258 Doxycycline Antibacterial Human Plasma K3EDTA LC/MS/MS API3000 10.0 7000
    259 Doxycycline Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 10.0 7000
    260 Dronedarone+ Desbutyl Dronedarone Antiarrhythmic Human Plasma K3EDTA LC/MS/MS Premier XE 0.50
    0.50    		 300
    300
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    261 Droxidopa Parkinson's disease Human Plasma K3EDTA LC/MS/MS API 4000 10.0 6000
    262 Droxidopa Parkinson's disease Human Plasma K3EDTA LC/MS/MS API 4000 10.0 6000
    263 Duloxetine Antidepressant Human Plasma CPDA, EDTA LC/MS/MS API 2000 0.40 150
    264 Duloxetine Antidepressant Human Plasma K3EDTA LC/MS/MS API 2000 0.50 100
    265 Dutastaride 5-alpha-reductase inhibitor Human Plasma K3EDTA LC/MS/MS API-4000 0.10 25.0
    266 Dutasteride Benign prostatic hyperplasia Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.010 10.0
    267 Dutasteride + Tamsulosin BPH (Benign prostatic hyperplasia) Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.020
    0.10    		 10.0
    50.0
    268 Efavirenz Antiviral Human Plasma EDTA HPLC HPLC-UV 50.0 9000
    269 Efavirenz Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 30.0 6000
    270 Eletriptan Anti-Migraine Human Plasma Na Heparin LC/MS/MS Premier XE 0.50 250
    271 Eliglustat Gaucher's disease Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10 100
    272 Eltrombopag Thrombocytopenia Human Plasma EDTA LC/MS/MS Premier XE 50.0 30000
    273 Empagliflozin Antidiabetic Human Plasma K3EDTA LC/MS/MS LCMS-8050 3.00 1200
    274 Emtricitabin Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 30.0 3000
    275 Emtricitabine + Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 20.0
    4.00    		 4000
    800
    276 Emtricitabine + Tenofovir Alafenamide Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8040 20.0
    2.00    		 5000
    500
    277 Enalapril + Enalaprilat Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 5.00
    2.00    		 1000
    450
    278 Enalapril + Enalaprilate Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 1.00
    0.50    		 500
    250
    279 Enalapril + Enalaprilate Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 1.00
    0.50    		 500
    250
    280 Entacapone + Metabolite Parkinson's disease Human Plasma K3EDTA HPLC HPLC-UV 50.0 6000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    281 Entacapone + Metabolite Parkinson's disease Human Plasma K3EDTA LC/MS/MS Premier XE 25.0 6000
    282 E-Entacapone Parkinson's disease Human Plasma K3EDTA LC/MS/MS API 4000 10.0 5000
    283 Entecavir Antiviral Human Plasma K3EDTA LC/MS/MS API 5500 0.040 20.0
    284 Enzalutamide Metastatic castration-resistant prostate cancer (CRPC) Human Plasma K3EDTA LC/MS/MS API 2000 10.0 10000
    285 Enzalutamide Metastatic castration-resistant prostate cancer (CRPC) Human Plasma K3EDTA LC/MS/MS API 2000 20.0 10000
    286 Eplerenone Chronic Heart Failure Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 4000
    287 Eprosartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 30.0 4000
    288 Eprosartan + Hydrochlorothiazide Antihypertensive Diuretic Human Plasma K3EDTA LC/MS/MS API 3000 30.0
    1.00    		 7500
    500
    289 Eprosartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 30.0 6000
    290 Erlotinib Anticancer Human Plasma Na Heparin LC/MS/MS Premier XE 12.5 2500
    291 Erlotinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 1.00 2500
    292 Erythromycin Antibacterial Human Plasma EDTA LC/MS/MS API 2000 20.0 2000
    293 Erythromycin Antimicrobial Human Plasma K3EDTA LC/MS/MS Premier XE / API4000 10.0 4000
    294 Escitalopram Antidepressant Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.30/td> 200
    295 Escitalopram Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.20 50.0
    296 Escitalopram + S (+) Desmethylcitalopram Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.20
    0.040    		 50.0
    10.0
    297 Eslicarbazepine Antiepileptic Human Plasma EDTA LC/MS/MS API 2000 100 30000
    298 Esomeprazole Proton pump inhibitor Human Plasma CPDA, EDTA LC/MS/MS API 2000 10.0 3500
    299 Esomeprazole (Sensitive) Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 2000 5.00 3500
    300 Esomeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 10.0 4000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    301 Esomeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 3000 2.00 800
    302 Esomeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 2.00 800
    303 Esomeprazole + Naproxen Proton pump inhibitor NSAID Human Plasma K3EDTA LC/MS/MS API 4000 5.0
    500    		 1500
    150000
    304 Esomeprazole+ Naproxen Proton pump inhibitor NSAID Human Plasma K3EDTA LC/MS/MS API 4000 2.0
    500    		 600
    150000
    305 Ethinyl Esterdiol + Levonorgetral Oestrogen Human Plasma Sodium Heparin LC/MS/MS API 5500 0.004
    0.10    		 0.50
    20.0
    306 Ethosuximide Anticonvulsant Human Plasma K3EDTA LC/MS/MS LCMS-8050 50.0 20000
    307 Ethosuximide Antiepileptic Human Plasma K3EDTA LC/MS/MS API 4000 800 200000
    308 Etodolac Non-steroidal Anti- inflammatory Human Plasma K3EDTA LC/MS/MS API 2000 500 80000
    309 Etodolac Nonsteroidal anti-inflammatory Human Plasma K3EDTA LC/MS/MS Premier XE 250 80000
    310 Etoposide Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 20.0 8000
    311 Etoricoxib COX-2 selective inhibitor Human Plasma K3EDTA LC/MS/MS API2000 10.0 5000
    312 Etravirine Antiviral Human Plasma EDTA LC/MS/MS LCMS-8050 2.00 1200
    313 Everolimus Anticancer Human Blood K3EDTA LC/MS/MS API3000 0.30 200
    314 Exemestane Aromatase inhibitor, Anticancer Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.10 40.0
    315 Ezetimib + Ezetimibe-O-beta-glucuronide Antihyperlipidemic Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.10
    1.00    		 25.0
    250
    316 Ezetimibe + Ezetimibe Phenoxy Glucuronide Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500 0.10
    1.00    		 30.0
    300
    317 Ezetimibe(Unconjugated) Antihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.13 20.0
    318 Ezetimib (Total) Antihyperlipidemic Human Plasma CPDA, EDTA LC/MS/MS LCMS-8040 1.000 200.0
    319 Ezetimibe+ Ezetimibe Phenoxygluconoride Antihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.10
    1.00    		 15.0
    150
    320 Famotidine Antihistamine (H2 Antagonist) Human Plasma K3EDTA LC/MS/MS API 4000 1.00 300
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    321 Febuxostat Inhibitor of Xanthine Oxidase Human Plasma K3EDTA LC/MS/MS API 4000 50 10000
    322 Felodipine Antihypertensive Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.20 10.0
    323 Felodipine Calcium channel blocker Human Plasma K3EDTA LC/MS/MS API 4000 0.10 10.0
    324 Felodipine Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.015 15.0
    325 Fenofibric Acid Antihyperlipidemic Human Plasma Sodium Heparin LC/MS/MS API 2000 25.0 10000
    326 Fenofibric Acid Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 20000
    327 Fenofibric Acid Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 2000 50.0 20000
    328 Fenoprofen Non-steroidal Anti- inflammatory Human Plasma K3EDTA LC/MS/MS API 3000 250 100000
    329 Fesoterodine + 5-Hydyroxy methyl tolterodine Urinary Iincontinence Human Plasma K3EDTA LC/MS/MS API 5500 0.001
    0.02    		 0.750
    15.0
    330 Fexofenadine Antihistamine Human Plasma CPDA, EDTA LC/MS/MS API 2000 8.00 1000
    331 Fexofenadine Antihistaminer Human Plasma K3EDTA LC/MS/MS API 3000 4.00 2000
    332 Fexofenadine Antihistamine Human Plasma EDTA LC/MS/MS API 3000 4.00 2000
    333 Fexofenadine + Pseudoephedrine Antihistamine Human Blood K3EDTA LC/MS/MS API 4000 2.00 1500
    334 Fexofenadine + Pseudoephedrine (Sensitive) Antihistamine Human Plasma CPDA, EDTA LC/MS/MS Premier XE 1.00
    2.00    		 500
    1000
    335 Flibanserin HypoactiveSsexual Desire Disorder (HSDD) Human Plasma Na Heparin LC/MS/MS API 4000 4.00 1400
    336 Fingolimod Multiple sclerosis Human Blood K3EDTA LC/MS/MS API 5500 0.010 5.00
    337 Flecainide Anti–arrhythmic Human Plasma EDTA LC/MS/MS Premier XE 2.00 800
    338 Fluconazole Antifungal Human Plasma CPDA, EDTA LC/MS/MS API 2000 50 10000
    339 Fluconazole Antifungal Human Plasma EDTA LC/MS/MS API 3000 20.0 8000
    340 Flucytosine Antimycotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    341 Flucytosine Antifungal Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0
    342 Fludrocortisone Glucocorticoid Human Plasma CPDA, EDTA LC/MS/MS API 5500 0.025 2.50
    343 Fluoxetine Antidepressant Human Plasma K3EDTA LC/MS/MS API 4000 0.20 100
    344 Fluoxetine + Norfluoxetine Antidepressant Human Plasma EDTA LC/MS/MS API 4000 2.00 400
    345 Fluphenazine Antipsychotic Human Plasma Sodium Heparin LC/MS/MS LCMS-8040 0.020 5.00
    346 Free Dabigatran Thrombin Inhibitor Human Plasma Sodium citrate LC/MS/MS LCMS-8050 1.000 400
    347 Fulvestrant Anticancer Human Plasma K3EDTA LC/MS/MS API 3000 0.10 25.0
    348 Furosemide Diuretic Human Plasma K3EDTA LC/MS/MS LCMS-8050 20.0 6000
    349 Gabapentin Anticonvulsant Human Plasma EDTA LC/MS/MS API 2000 40.0 10000
    350 Gabapentin Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 40.0 6000
    351 Galantamine Alzheimer's disease Human Plasma K3EDTA LC/MS/MS Premier XE 0.25 150
    352 Gefitinib Anticancer Human Plasma EDTA LC/MS/MS API 4000 0.50 250
    353 Gefitinib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 1.50/td> 450
    354 Glibenclamide (Glyburide) Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 1.00 500
    355 Glibenclamide (Glyburide) Antidiabetic Human Plasma Na Heparin LC/MS/MS API 2000 2.00 800
    356 Glibenclamide + Metformin Antidiabetic Human Blood K3EDTA LC/MS/MS LCMS-8050 2.00
    10.0    		 600
    3000
    357 Gliclazide Antidiabetic Human Plasma EDTA LC/MS/MS API 2000 50.0 5000
    358 Gliclazide Antidiabetic Human Plasma CPDA, EDTA LC/MS/MS API 2000 50.0 12000
    359 Glimepiride Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 1.00 500
    360 Glimpiride Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 1.00 500
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    361 Glimepiride Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 2.00 800
    362 Glipizide Antidiabetic Human Plasma CPDA, EDTA LC/MS/MS API 2000 5.00 2000
    363 Glycopyrronium Anticholinergic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 pg/mL 500 pg/mL
    364 Griseofulvin Antifungal Human Plasma K3EDTA LC/MS/MS API 2000 10.0 4000
    365 Granisetron Anti–emetic Human Plasma EDTA LC/MS/MS API 2000 0.15 15
    366 Granisetron Anti–emetic Human Plasma Sodium citrate LC/MS/MS API 3000 0.10 30.0
    367 Granisetron Anti–emetic Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.15 150
    368 Griseofulvin Antifungal Human Plasma K3EDTA LC/MS/MS API 2000 10.0 5000
    369 Guaifenesin Expectorant Human Plasma EDTA LC/MS/MS API 2000 43.77 5606
    370 Guaifenesin Expectorant Human Plasma K3EDTA LC/MS/MS Premier XE 15.0 6000
    371 Guaifenesin Expectorant Human Plasma K3EDTA LC/MS/MS Premier XE 12.5 5000
    372 Guanfacine Antihypertensive Human Plasma EDTA LC/MS/MS API 5500 0.025 10.0
    373 Guanfacine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 0.05 20.0
    374 Hydralazine Antihypertensive Human Plasma EDTA LC/MS/MS LCMS-8050 0.20 200
    375 Hydrochlorothiazide Diuretic Human Plasma EDTA LC/MS/MS API 2000 2.00 500
    376 Hydrochlorothiazide Diuretic Human Plasma EDTA LC/MS/MS API 3000 1.00 500
    377 Hydrochlorothiazide Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 1.00 250
    378 Hydrochlorothiazide + Irbesartan Antihypertensive Diuretic Human Plasma CPDA, EDTA LC/MS/MS API 3000 1.00
    30.0    		 250
    7500
    379 Hydrochlorothiazine + Telmisartan Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 1.50
    5.00     		300
    1000
    380 Hydrochlorothiazide + Metoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 1.00
    0.15    		 500
    75.0
  • Validated Method List (Generics)
    669
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    381 Hydrocortisone Glucocorticoid Human Plasma K3EDTA LC/MS/MS API 4000 0.50 1000
    382 Hydrocortisone (Free ) Glucocorticoid Human PlasmaCPDA, EDTA LC/MS/MS LCMS-8050 0.10 80.0
    383 Hydrocortisone (Free ) Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10 50.0
    384 Hydrocortisone (Total) Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 500
    385 Hydroxycarbamide (Hydroxyurea) Anticancer Human Plasma EDTA LC/MS/MS API 4000 100 30000
    386 Hydroxychloroquine Antimalarial Human Plasma Sodium citrate LC/MS/MS API 2000 2.00 600
    387 Ibrutinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.50 100
    388 Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 500 100000
    389 Ibuprofen NSAID Human Plasma EDTA LC/MS/MS Premier XE 150 30000
    390 Ibuprofen NSAID Human Plasma K3EDTA LC/MS/MS API 4000 250 100000
    391 Idelasisib Chronic lymphocytic leukemia Human Plasma K3EDTA LC/MS/MS API 3200 10.0 4000
    392 Imatinib Anticancer Human Plasma EDTA LC/MS/MS API2000 25.0 8000
    393 Imatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 2000 25.00 6000
    394 Imatinib + N-Desmethyl Imatinib Anticancer Human Plasma EDTA LC/MS/MS API 3200 20.0 2.00 10000 1000
    395 Indapamide Antihypertensive Human Blood K3EDTA LC/MS/MS API 4000 0.20 100
    396 Indomethacin Nonsteroidal anti-inflammatory Human Plasma EDTA LC/MS/MS API 2000 25.0 5000
    397 Indoramin Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 0.04 80
    398 Ipratropium Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.60 pg/mL 180 pg/mL
    399 Irbesartan + Hydrochlorothiazide Antihypertensive Diuretic Human Plasma EDTA LC/MS/MS API 3000 10.0
    1.00     		5000
    500
    400 Irbesartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 30.0 7500
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    401 Iron Iron Defficiency Anaemia Human Plasma K3EDTA ICP OES Optima 8000 400 20000
    402 Isosorbide 5-mononitrate Angina Pectoris, Congestive Heart Failure Human Plasma K3EDTA LC/MS/MS API 5500 10.0 1000
    403 Isotretinoin Anti-acne Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 2000
    404 Isotretinoin Anti-acne Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 1000
    405 Itraconazole Antifungal Human Plasma CPDA, K3EDTA LC/MS/MS API 4000 2.00 600
    406 Itraconazole Antifungal Human Plasma Sodium citrate LC/MS/MS LCMS-8050 1.00 1000
    407 Itraconazole + Hydroxy Itraconazole Antifungal Human Plasma K3EDTA LC/MS/MS API 3000 2.00 600
    408 Ivabradine Heart rate lowering agent Human Plasma K3EDTA LC/MS/MS Premier XE 0.25 100
    409 Ivabradine + N-desmethyi ivabradine Heart rate lowering agent Human Plasma K3EDTA LC/MS/MS API 4000 0.20
    0.050    		 100
    25.0
    410 Ivacaftor Cystic fibrosis Human Plasma K3EDTA LC/MS/MS API 3200 2.00 2000
    411 Ivermectin anthelmintics Human Plasma K3EDTA LC/MS/MS API 4000 0.20 80.0
    412 Ketoprofen Anti-Inflammatory, Analgesic Human Plasma EDTA LC/MS/MS API 3000 20.0 10000
    413 Ketorolac Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 2000
    414 Ketotifen NSAID Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.002 1.00
    415 Lacosamide Antiepileptic Human Blood K3EDTA LC/MS/MS LCMS-8040 50.0 10000
    416 Labetalol Antihypertensive Human Plasma EDTA LC/MS/MS Premier XE 1.0 500
    417 Lacosamide Antiepileptic Human Plasma K3EDTA LC/MS/MS LCMS-8040 50.0 20000
    418 Lamivudine Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 60.0 6000
    419 Lamivudine Antiviral Human Plasma EDTA LC/MS/MS API 2000 20.0 6000
    420 Lamivudine + Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 3200 20.0
    5.00    		 4000
    1000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    421 Lamivudine + Zidovudine Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 40.0
    60.0    		 4000
    6000
    422 Lamivudine + Abacavir Antiviral Human Plasma EDTA LC/MS/MS API 3000 55.0
    30.0    		 11000
    6000
    423 Lamivudine +
    Nevirapine +
    Zidovudine     		Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 50.0 6000
    424 Lamuvudine +
    Nevirapine +
    Zidovudine    		 Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 40.0
    50.0
    60.0    		 4000
    5000
    6000
    425 Lamotrigine Anticonvulsant, Anti–epileptic Human Plasma CPDA, K3EDTA LC/MS/MS Premier XE 40.0 10000
    426 Lamotrigine Anticonvulsant, Anti–epileptic Human Plasma Sodium citrate LC/MS/MS API 4000 5.00 4000
    427 Lamotrigine Anticonvulsant, Anti–epileptic Human Plasma K3EDTA LC/MS/MS API 3200 20.0 10000
    428 Lansoprazole Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 4000 5.00 2000
    429 Lansoprazole/td> Proton pump inhibitor Human Plasma EDTA LC/MS/MS API 4000 2.00 2000
    430 Lansoprazole Proton-pump inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 5.00 2500
    431 Lansoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 2.50 2500
    432 Lansoprazole Proton pump inhibito Human Plasma EDTA LC/MS/MS API 4000 2.50 2500
    433 Lapatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 10.0 5000
    434 Lapatinib Anticancer Human Plasma K3EDTA LC/MS/MS API 3200 3.00 1500
    435 Ledipasvir + Sofosbuvir Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00
    3.00    		 1000
    1500
    436 Lenalidomide Anticancer (Multiple myeloma) Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 1000
    437 Lenalidomide Anticancer (Multiple myeloma) Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50 100
    438 Lenvatinib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 0.40 400
    439 Letrozole Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 100
    440 Letrozole Breast Cancer Human Plasma K3EDTA LC/MS/MS API 3200 1.00 400
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    441 Leuprolide (Leuprorelin) Prostate cancer, Breast cancer Human Serum NA LC/MS/MS API 5500 40.0
    60.0    		 4000
    6000
    442 Leuprolide (Leuprorelin) Prostate cancer, Breast cancer Human Serum NA LC/MS/MS LCMS-8050 0.50 200
    443 Leuprolide (Leuprorelin) Prostate cancer, Breast cance Human Serum NA LC/MS/MS LCMS-8050 0.020 120
    444 Levetiracetam Anti–epileptic Human Plasma K3EDTA LC/MS/MS Premier XE 300 60000
    445 Levetiracetam Anti–epileptic Human Plasma K3EDTA LC/MS/MS Premier XE 300 60000
    446 Levocarnitine Primary systemic carnitine deficiency Human Plasma K3EDTA LC/MS/MS LCMS-8040 100 20000
    447 Levocetirizine Non-sedative antihistamine Human Plasma K3EDTA LC/MS/MS API 3000 10.0 600
    448 Levofloxacin Antibacterial Human Plasma EDTA LC/MS/MS API 2000 100 16000
    449 Levofloxacin Antibacterial Human Plasma EDTA LC/MS/MS API 2000 80.0 20000
    450 Levofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 80.0 20000
    451 Levomepromazine Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.025 15.0
    452 Levosalbutamol Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.005 1.00
    453 Levothyroxine Thyroid Hormone Defficiency Human Serum NA LC/MS/MS Premier XE 10.0 1000
    454 Levothyroxine + Liothyronine Thyroid Hormone Defficiency Human Serum NA LC/MS/MS LCMS-8050 20.0
    0.30    		 1000
    15.0
    455 Levothyroxine + Liothyronine Thyroid Hormone Defficiency Human Serum NA LC/MS/MS LCMS-8050 20.0
    0.30    		 800
    12.0
    456 Lidocaine Local Anesthetic Human Plasma K3EDTA LC/MS/MS API 4000 0.200 200
    457 Lidocaine + Prilocaine Local Anesthetic Human Plasma K3EDTA LC/MS/MS API 4000 0.60 0.40 300 200
    458 Linagliptin Antidiabetic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.035 14.0
    459 Linezolid Antibiotic Human Plasma K3EDTA LC/MS/MS API 3000 100 24000
    460 Lisinopril Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 1.00 200
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    461 Lisinopril Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.50 60
    462 Lisinopril Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 200
    463 Lisinopril Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 1.00 700
    464 Lithium Antidepressant Human Plasma K3EDTA ICP OES Optima 8000 50.0 5000
    465 Loperamide Antidiarrheal Human Plasma K3EDTA LC/MS/MS API 5500 0.010 4.00
    466 Loperamide Antidiarrheal Human Plasma K3EDTA LC/MS/MS API 5500 0.005 6.00
    467 Loperamide + N-Desmethyl Loperamide Antidiarrheal Human Plasma K3EDTA LC/MS/MS API 5500 0.010
    0.010    		 4.00
    4.00
    468 Lopinavir + Ritonavir Antiretroviral Human Plasma K3EDTA LC/MS/MS Premier XE 30.0
    3.00    		 15000
    1500
    469 Loratadine + Desloratadine Antihistamine Human Plasma CPDA, EDTA LC/MS/MS API 4000 0.20 50.0
    470 Loratadine Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.075 25.0
    471 Lorcaserin Weight Loss Human Plasma K3EDTA LC/MS/MS API 4000 0.40 200
    472 Losartan Angiotensin II Receptor Antagonist Human Plasma K3EDTA LC/MS/MS API 3000 1.00 500
    473 Lumefantrine Antimalarial Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 20000
    474 Lumafantrine Antimalarial Human Plasma K3EDTA LC/MS/MS API 3200 50.0 30000
    475 Lurasidone Antipsychotic Human Serum NA LC/MS/MS API4000 0.25 150
    476 Lurasidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.25 150
    477 Magnesium Hypomagnesaemia Human Serum NA ICP OES Optima 8000 2000 150000
    478 Magnesium Hypomagnesaemia Human Urine NA ICP OES Optima 8000 2000 350000
    479 Macitentan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 1.00 500
    480 Maraviroc Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 0.50 500
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    481 Mebendazole Anthelmintic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.020 30.0
    482 Meclizine Antihistamine Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50 300
    483 Mefenamic Acid (Sensitive) Non-steroidal Anti- inflammatory Human Plasma K3EDTA LC/MS/MS API 2000 40.5 12000
    484 Mefenamic Acid (Sensitive) Non-steroidal Anti- inflammatory Human Plasma K3EDTA LC/MS/MS API 3000 20.0 11000
    485 Mefenamic acid Non steroial anti inflammatory Human Plasma K3EDTA LC/MS/MS API 2000 30.0 12000
    486 Meloxicam NSAID Human Plasma K3EDTA LC/MS/MS API 4000 20.0 8000
    487 Memantine Anti-Alzheimer's Human Plasma EDTA LC/MS/MS API 3000 0.50 100
    488 Mexiletine Antiarrhythmic Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 1000
    489 Mercaptopurine Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 4000 0.50 80.0
    490 Mesalamine Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 4000 2.00 2000
    491 Mesalamine Anti-inflammatory Human Plasma K3EDTA LC/MS/MS API 4000 2.00 2000
    492 Mesalamine Anti-inflammatory Human Plasma K3EDTA LC/MS/MS Waters QPXE 25.0 12500
    493 Metaxalone Muscle Relaxant Human Plasma K3EDTA LC/MS/MS API 2000 10.0 5000
    494 Metformin Antidiabetic Human Plasma EDTA HPLC HPLC-UV 40.0 7500
    495 Metformin Antidiabetic Human Serum NA LC/MS/MS API 2000 40.0 7500
    496 Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 20.0 7500
    497 Metformin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 4.00 800
    498 Metformin + Sitagliptin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000 10.0
    2.00    		 4000
    800
    499 Metformin + Vildagliptin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000 10.0
    2.00    		 4000
    800
    500 Metformin + Vildagliptin Antidiabetic Human Plasma K3EDTA LC/MS/MS API 4000 5.00
    2.00    		 4000
    1600
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    501 Mebendazole Urinary Tract Infection Human Plasma K3EDTA LC/MS/MS API 3200 0.050 20.0
    502 Methimazole Antithyroid Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00 500
    503 Methocarbamol Musculoskeletal relaxant Human Plasma K3EDTA LC/MS/MS Premiere XE 100 30000
    504 Methotrexate Anticancer Human Plasma EDTA LC/MS/MS Premier XE 1.00 250
    505 Methotrexate Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 2.00 600
    506 Methoxsalen Dermatological Human Plasma EDTA LC/MS/MS API 4000 1.00 200
    507 Methoxsalen (Sensitive) Dermatological Human Plasma EDTA LC/MS/MS API 4000 0.10 100
    508 Methyl Ergonovine Postpartum Hemorrhage Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.040 10.0
    509 Methylphenidate CNS Stimulant Human Plasma K3EDTA LC/MS/MS API 4000 0.20 100
    510 Methyl Prednisolone corticosteroid hormone Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.050 40
    511 Methyl Prednisolone Glucocorticoid Human Plasma K3EDTA LC/MS/MS API 3000 0.20 100
    512 Methyl Prednisolone Glucocorticoid Human Plasma K3EDTA LC/MS/MS LCMS-8040 5.00 4000
    513 Metolazone Diuretic Human Plasma K3EDTA LC/MS/MS API 5500 0.15 150
    514 Metolazone Diuretic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 250
    515 Metopimazine + Metopimazine Acid Antiemetic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20
    0.40    		 100
    200
    516 Metoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 2000 0.30 300
    517 Metoprolol Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.30 300
    518 Metoprolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.30 300
    519 Metronidazole Antiamoebic Human Plasma CPDA, EDTA HPLC HPLC-UV 100 40000
    520 Metronidazole Antiamoebic Human Plasma K3EDTA LC/MS/MS Premier XE 100 40000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    521 Metronidazole Antiamoebic Human Stool NA LC/MS/MS API 4000 0.50 250
    522 Midazolam + 1-Hydroxy Midazolam Anxiolytic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.30
    0.10    		 60.0
    20.0
    523 Minocycline Antibiotic Human Plasma Na Heparin LC/MS/MS API 4000 10.0 3000
    524 Minocycline Antibiotic Human Plasma EDTA LC/MS/MS API 4000 10.0 3000
    525 Mirabegron Urinary incontinence Human Plasma Na Heparin LC/MS/MS API 5500 0.100 80.0
    526 Mometasone Corticosteroid, Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.20 pg/mL 30.0 pg/mL
    527 Mono Methyl Fumarate Multiple Sclerosis Human Plasma EDTA LC/MS/MS API 3000 10.0 5000
    528 Montalukast+ Fexofenadin leukotriene receptor antagonist Antihistamine Human Plasma K3EDTA LC/MS/MS API 4000 2.00 1000
    529 Montelukast Lukotriene receptor antagonist Human Plasma K3EDTA LC/MS/MS API 4000 5.00 1000
    530 Montelukast eukotriene receptor antagonist Human Plasma EDTA LC/MS/MS API 4000 5.00 1000
    531 Montelukast Lukotriene receptor antagonist Human Plasma K3EDTA LC/MS/MS API 4000 1.00 400
    532 Moxifloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 40.0 5000
    533 Moxifloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 40.0 10000
    534 Moxifloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000 30.0 15000
    535 Mycophenolic acid Immunosuppressant Human Plasma CPDA, EDTA LC/MS/MS API 4000 300 50000
    536 Mycophenolic acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 3000 40.5 20000
    537 Mycophenolate Acid Immunosuppressant Human Plasma EDTA LC/MS/MS API 3000 40.0 20000
    538 Mycophenolic Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS Premier XE 200 50000
    539 Mycophenolic Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 4000 0.0 20000
    540 Mycophenolic Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 3000 60.0 30000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    541 Mycophenolic acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 4000 100 50000
    542 Mycophnolic Acid Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 3000 60.0 30000
    543 Mycophenolate Mofetil Immunosuppressant Human Plasma CPDA, EDTA LC/MS/MS API 4000 20.0 800
    544 Mycophenolate Mofetil Immunosuppressant Human Plasma EDTA LC/MS/MS API 4000 0.10 16.0
    545 Mycophenolate Mofetil Immunosuppressant Human Plasma K3EDTA LC/MS/MS API 5500 0.01 10.0
    546 Nadolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 1.00 600
    547 Nafithromycin Antibiotic Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 5000
    548 Naltrexone + 6ß Naltrexone Opioid antagonist Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10
    0.50    		 35.0
    175
    549 Naproxen NSAID Human Plasma K3EDTA LC/MS/MS API 4000 10.0 10000
    550 Naproxen Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 500 150000
    551 Naproxen NSAID Human Plasma K3EDTA LC/MS/MS API 3200 400 200000
    552 Naratriptan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 20.0
    553 Naratriptan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.050 25.0
    554 Nateglinide Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3000 50.0 12000
    555 Nebivolol Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.05 5.00
    556 Nebivolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 0.04 15.0
    557 Nebivolol Antihypertensive Human Plasma K3EDTA LC/MS/MS API 5500 0.030 40.0
    558 Nefopam Analgesic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 200
    559 Nefopam Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.50 200
    560 Nevirapine Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 50.00 5000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    561 Nicardipine Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20 130
    562 Nifedipine Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 0.40 200
    563 Nifedipine Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 50.0
    564 Nifedipine Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.25 100
    565 Nifedipine Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 250
    566 Nilutamide Antiandrogen Human Plasma K3EDTA LC/MS/MS API 4000 40.0 8000
    567 Nilotinib Anticancer Human Plasma K3EDTA LC/MS/MS API 3000 6.00 3000
    568 Nilotinib Anticancer Human Plasma K3EDTA LC/MS/MS API 3000 12.0 6000
    569 Nimodipine Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.20 50.0
    570 Nintedanib Idiopathic pulmonary fibrosis (IPF) Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0
    571 Nitisinone Hereditary tyrosinemia type 1 (HT-1) Human Plasma NA LC/MS/MS API 4000 10.0 10000
    572 Nitrofurantoin Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 10.0 1500
    573 Nitrofurantoin Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 2.00 600
    574 Nitrofurantoin Antibiotic Human Plasma K3EDTA LC/MS/MS API 5500 0.75 1500
    575 Nizatidine Antihistamine Human Plasma K3EDTA LC/MS/MS API 4000 20.0 5000
    576 Norethisterone (Norethindrone) Progestogen Human Plasma K3EDTA LC/MS/MS API 5500 0.50 100
    577 Norfloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 25.0 8000
    578 Nortriptyline Antidepressant Human Plasma EDTA LC/MS/MS API 3000 0.50 220
    579 Nortriptyline Antidepressant Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 50.0
    580 Nortryptiline + E-10-Hydroxy Nortryptiline Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10
    0.20    		 50.0
    100
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    581 Octreotide Growth hormone producing tumors Human Plasma K3EDTA LC/MS/MS LCMS-8060 0.050 15.0
    582 Ofloxacin Antibacterial Human Plasma K3EDTA LC/MS/MS API 2000 25.0 8000
    583 Olanzapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3000 0.50 50.0
    584 Olaparib Anticancer Human Plasma K3EDTA LC/MS/MS API 3200 50.0 20000
    585 Olmesartan Angiotensin II receptor antagonis Human Plasma K3EDTA LC/MS/MS API 4000 10.0 3000
    586 Olmesartan + Hydrochlorothiazide Angiotensin II receptor antagonist diuretic Human Plasma K3EDTA LC/MS/MS API 4000 10.0
    1.00    		 3000
    300
    587 Olanzepine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 30.0
    588 Olanzapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 3200 0.30 120
    589 Olsalazine Ulcerative colitis Human Plasma K3EDTA LC/MS/MS API 4000 20.0 2000
    590 Omeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 5.00 2000
    591 Omeprazole Proton Pump Inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 2.00 2000
    592 Ondansetron Anti–emetic Human Plasma K3EDTA LC/MS/MS API 5500 0.20 80.0
    593 Orphenadrine Antihistamine Human Plasma K3EDTA LC/MS/MS API 2000 4.00 800
    594 Oseltamivir + Oseltamivir Carobxylate Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50
    2.00    		 250
    1000
    595 Oseltamivir + Oseltamivir Carboxylate Antiviral Human Plasma K3EDTA LC/MS/MS API 3000 0.50
    2.00    		 200
    800
    596 Osimertinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.25 200
    597 Ospemifene Dyspareunia Human Plasma NA LC/MS/MS LCMS-8040 5.00 2000
    598 Oxaprozin Total NSAID Human Plasma K3EDTA LC/MS/MS LCMS-8040 500 160000
    599 Oxcarbazepine + 10, 11-Dihydro-10-hydroxy-Carbamazepine Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 2000 20.0
    75.0    		 4000
    15000
    600 Oxybutynin + Metabolite- N-Desethyl Oxybutynin Anticholinergic Human Plasma K3EDTA LC/MS/MS API 4000 0.05
    0.50    		 10.0
    100
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    601 Oxybutynin + N-Desethyl Oxybutynin Anticholinergic Human Plasma K3EDTA LC/MS/MS API 4000 0.050
    0.20    		 50.0
    200
    602 Paclitaxel (Total) Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 5.00 15000
    603 Paclitaxel (Total) Anticancer Human Plasma Na Heparin LC/MS/MS API 4000 80.0 40000
    604 Palbociclib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200
    605 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 150
    606 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.10 50.0
    607 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.050 50.0
    608 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.50 250
    609 Paliperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 0.20 120
    610 Pantoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 15.0 5000
    611 Pantoprazole Proton Pump Inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 10.0 6000
    612 Pantoprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 10.0 8000
    613 Paroxetine Antidepressant Human Plasma K3EDTA LC/MS/MS API 3000 0.40 200
    614 Paroxetine Antidepressant Human Plasma K3EDTA LC/MS/MS API 2000 0.40 60.0
    615 Paroxetine Antidepressant Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.040 24.0
    616 Pazopanib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 100 40000
    617 Pazopanib Anticancer Human Plasma NA LC/MS/MS API 4000 100 80000
    618 Pazopanib Anticancer Human Plasma K3EDTA LC/MS/MS API 3200 300 150000
    619 Pazopanib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 2300 150000
    620 Pemetrexed Lung Cancer Human Plasma K3EDTA LC/MS/MS API 3200 500 200000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    621 Perampanel Antiepileptic Human Plasma K3EDTA LC/MS/MS Premier XE 1.00 1000
    622 Phenobarbital Antiepileptic Human Plasma K2EDTA LC/MS/MS Premier XE 10.0 4000
    623 Phenytoin Antiepileptic Human Plasma K3EDTA LC/MS/MS API 4000 10.0 5000
    624 Phenytoin Phenytoin Human Plasma K3EDTA LC/MS/MS API 3200 60.0 12000
    625 Phloroglucinol Antispasmodic Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 2500
    626 Phloroglucinol Antispasmodic Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 2500
    627 Pimozide Antipsychotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.02 5.00
    628 Pindolol Beta Blocker Human Plasma K3EDTA LC/MS/MS API 2000 1.00 400
    629 Pioglitazone + Hydroxy Pioglitazone M IV Antihyperglycemic, antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 10.0
    5.00    		 3000
    1500
    630 Piperaquine Antimalarial Human Plasma K3EDTA LC/MS/MS API 4000 2.00 300
    631 Piribedil Antiparkinsonian Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200
    632 Pirfenidone Idiopathic pulmonary fibrosis (IPF) Human Plasma K3EDTA LC/MS/MS LCMS-8050 50.0 25000
    633 Pirfenidone Idiopathic pulmonary fibrosis (IPF) Human Plasma K3EDTA LC/MS/MS LCMS-8050 50.0 30000
    634 Pirfenidone Idiopathic pulmonary fibrosis (IPF) Human Plasma K3EDTA LC/MS/MS LCMS-8050 10.0 10000
    635 Piroxicam NSAID Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 10000
    636 Pomalidomide Anticancer (Multiple Myeloma) Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50 150
    637 Posaconazole Antifungal Human Plasma K3EDTA LC/MS/MS API3000 2.00 2000
    638 Pramipexole Antiparkinsonian Human Plasma EDTA LC/MS/MS API 4000 0.02 4.00
    639 Pravastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8040 0.40 200
    640 Pravastatin Antihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.30 200
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    641 Praziquantel Anthelmintic Human Plasma K3EDTA LC/MS/MS API 3000 10.0 4000
    642 Prazosin Antihypertensive Human Plasma K2EDTA LC/MS/MS API 4000 0.20 60.0
    643 Pregabalin Anticonvulsant Human Plasma K3EDTA LC/MS/MS Premier XE 30.0 15000
    644 Pregabalin Anticonvulsant Human Plasma K3EDTA LC/MS/MS Premier XE 15.0 4000
    645 Pregabalin+
    Gabapentin+
    Carbamazepine+
    Levetiracetam    		 Antiepileptic Human Plasma K3EDTA LC/MS/MS Premier XE 30.0
    100
    10.0
    60.0    		 6000
    20000
    2000
    120000
    646 Primaquine Antimalarial Human Plasma K3EDTA LC/MS/MS API 3200 0.50 200
    647 Primidone Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 50.00 40000
    648 Primidone Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 10.0 3000
    649 Propafenone+ 5- Hydroxy Propafenone Antiarrhythmic Human Plasma K3EDTA LC/MS/MS API 4000 0.20
    0.20    		 400
    400
    650 Pottasium Hypokalaemia Human Plasma NA ICP OES Optima 8000 20000 3000000
    651 Prasugrel Metabolite R95913 Platelet Inhibitor (Prasugrel) Human Plasma K3EDTA LC/MS/MS API 4000 0.50 100
    652 Prochlorperazine Tranquilliser Human Plasma K3EDTA LC/MS/MS API 5500 0.002 0.600
    653 Prochlorperazine Tranquilliser Human Plasma K3EDTA LC/MS/MS API 5500 0.01 3.00
    654 Procyclidine Anticholinergic, Antiparkinsonian Human Plasma K3EDTA LC/MS/MS API 3200 1.00 300
    655 Proguanil Antimalarial Human Plasma K3EDTA LC/MS/MS API 3000 5.00 1000
    656 Promethazine Antihistaminic Human Plasma K3EDTA LC/MS/MS API2000 0.20 60.0
    657 Propofol Sedative-hypnotic Human Plasma K3EDTA LC/MS/MS API 5500 5.00 5000
    658 Propafenone + 5-Hydroxy metabolite Anti-arrhythmic Human Plasma K3EDTA LC/MS/MS Premier XE 5.00
    2.50    		 1000
    500
    659 Propranolol + 4-Hydroxy Propranolol(Free) Antihypertensive Human Plasma K3EDTA LC/MS/MS API 3000 0.10
    0.30    		 100
    30.0
    660 Pyrazinamide Antitubercular Human Plasma Na Heparin LC/MS/MS LCMS-8050 200 60000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    661 Pyridostigmine Anticholinesterase Human Plasma K3EDTA LC/MS/MS Anticholinesterase 0.50 150
    662 Pyridostigmine Anticholinesterase Human Plasma K2EDTA LC/MS/MS API 5500 0.50 150
    663 Pyrimethamine Antibacterial, Antimalarial Human Plasma K3EDTA LC/MS/MS API 3200 2.00 1000
    664 Quetiapine Antipsychotic Human Plasma EDTA LC/MS/MS Premier XE 2.00 2000
    665 Quetiapine Antipsychotic Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 200
    666 Quetiapine Antipsychotic Human Plasma K3EDTA LC/MS/MS API 4000 1.00 600
    667 Quinine Antimalarial Human Plasma K3EDTA LC/MS/MS API 2000 40.0 8000
    668 Quinidine Antianginal Human Plasma K3EDTA LC/MS/MS LCMS-8050 4.0 4000
    669 Rabeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 3.00 2000
    670 Rabeprazole Proton pump inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 3.00 1000
    671 Rabeprazole Proton pump inhibito Human Plasma K3EDTA LC/MS/MS API 2000 4.00 2000
    672 Raltegravir Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 20.0 3000
    673 Raltegravir Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 20.0 10000
    674 Raltegravir Antiviral Human Plasma K3EDTA LC/MS/MS API 4000 5.00 10000
    675 Ramipril Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 0.20 100
    676 Ramipril+ Ramiprilat Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 100
    677 Ranitidine Antihistamine (H2 Antagonist) Human Plasma EDTA LC/MS/MS API 2000 5.00 1000
    678 Ranitidine Antihistamine Human Plasma K3EDTA LC/MS/MS API 3000 10.0 3000
    679 Ranolazine Antianginal Human Plasma K3EDTA LC/MS/MS Premier XE 4.00 8000
    680 Ranolazine Antianginal Human Plasma Na Heparin LC/MS/MS Premiere XE 10.0 6000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    681 Rasagiline Parkinsons disease Human Plasma K3EDTA LC/MS/MS Waters 0.02 10.0
    682 Repaglinide Antidiabetic Human Plasma EDTA LC/MS/MS API 3000 0.50 200
    683 Repaglinide + 3-Hydroxy Repaglinide Antidiabetic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.050
    0.050    		 10.0
    10.0
    684 Rifampicin Antitubercular Human Plasma EDTA LC/MS/MS LCMS-8060 0.50 200
    685 Rifampicin + 25-Desacetyl Rifampicin Antitubercular Human Plasma K3EDTA LC/MS/MS API 4000 100
    10.0    		 20000
    2000
    686 Rifaximin Antibiotic Human Plasma K3EDTA LC/MS/MS API 4000 0.025 10.0
    687 Rifaximin Antibiotic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.009 12.0
    688 Rilpivirin Non-nucleoside Reverse Transcriptase Inhibitor Human Plasma K3EDTA LC/MS/MS API 2000 2.00 500
    689 Riluzole Amyotrophic lateral sclerosis Human Plasma K3EDTA LC/MS/MS Amyotrophic lateral sclerosis 1.00 500
    690 Risperidone + 9-Hydroxy Risperidone Antipsychotic Human Plasma K3EDTA LC/MS/MS Premier XE 0.20
    0.20    		 100
    100
    691 Ritonavir Antiretroviral Human Plasma K3EDTA LC/MS/MS Premier XE 2.50 1500
    692 Rivoroxaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS API 2000 1.00 800
    693 Rivaroxaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 500
    694 Rivaroxaban Oral Anticoagulant Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 800
    695 Rivastigmine Alzheimer's&Parkinson's Disease Human Plasma EDTA LC/MS/MS Premier XE 0.10 50.0
    696 Rizatriptan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 100
    697 Rizatriptan Anti-Migraine Human Plasma EDTA LC/MS/MS Premier XE 0.10 60.0
    698 Roflumilast Severe COPD associated with chronic bronchitis Human Plasma K3EDTA LC/MS/MS API 4000 0.100 20.0
    699 Roflumilast + Roflumilast N-Oxide Severe COPD associated with chronic bronchitis Human Plasma K3EDTA LC/MS/MS Premier XE 0.20
    0.25    		 40.0
    50.0
    700 Ropinirole Antiparkinsonian Human Plasma EDTA LC/MS/MS API 4000 0.02 4.00
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    701 Ropinirole Antiparkinsonian Human Plasma K3EDTA LC/MS/MS API 4000 0.02 4.00
    702 Rosiglitazone + Metformin Antidiabetic Human Plasma EDTA LC/MS/MS API 2000 6.00
    40.0    		 1100
    7600
    703 Rosiglitazone + N-Desmethyl Rosiglitazone Antidiabetic Human Plasma K3EDTA LC/MS/MS API 2000 5.00
    2.50    		 1000
    500
    704 Rosuvastatin Antihyperlipidemic Human Plasma EDTA LC/MS/MS Premier XE 0.60 100
    705 Rosuvastatin Lowering Cholestero Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 150
    706 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.50 200
    707 Rosuvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500 0.10 50.0
    708 Rotigotine Antiparkinsonian Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.002 1.20
    709 Rufinamide Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 30.0 9000
    710 Salmeterol Asthma Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.001 0.50
    711 Sacubitril + Valsartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 15.0
    25.0    		 6000
    10000
    712 Sacubitril +
    Sacubitrilat +
    Valsartan    		 Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 15.0
    50.0
    25.0    		 6000
    20000
    10000
    713 Scopolamine Anticholinergic Human Plasma K3EDTA LC/MS/MS API 4000 0.005 0.50
    714 Secnidazole Antiamoebic Human Plasma K3EDTA LC/MS/MS API 3200 200 80000
    715 Secnidazole Antiamoebic Human Plasma EDTA LC/MS/MS API 3000 200 80000
    716 Sertraline Antidepressant Human Plasma CPDA, EDTA LC/MS/MS API 2000 1.50 300
    717 Sertraline Antidepressant Human Plasma EDTA LC/MS/MS LCMS-8040 0.20 80.0
    718 Sildenafil Antihypertensive, Erectile dysfunction Human Plasma K3EDTA LC/MS/MS API 3000 8.00 1040
    719 Sildenafil + Metabolite Antihypertensive, Erectile dysfunction Human Plasma K3EDTA LC/MS/MS API 3000 2.00 1000
    720 Sildenafil + Piperazine N-desmethyl Sildenafil Antihypertensive, Erectile dysfunction Human Plasma K3EDTA LC/MS/MS API 3000 5.00
    1.00    		 2000
    400
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    721 Sildenafil + N-desmethyl sildenafil Antihypertensive, Erectile dysfunction Human Plasma K3EDTA LC/MS/MS API 4000 1.00
    0.20    		 500
    100
    722 Sildenafil + N-desmethyl Sildenafil Antihypertensive, Erectile dysfunction Human Plasma K3EDTA LC/MS/MS LCMS-8050 1.00
    0.20    		 500
    100
    723 Silodosin + Silodsoin Glucuronide Benign prostatic hyperplasia Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.50
    0.40    		 300
    240
    724 Siimvastatin Antihyperlipidemic Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.040 20.0
    725 Simvastatin Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.040 32.0
    726 Simvastatin Acid Antihyperlipidemic Human Plasma Na Heparin LC/MS/MS LCMS-8050 0.02 7.50
    727 Simvastatin Acid Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.015 12.0
    728 Simvastatin + β - hydroxy Acid Antihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.50 100
    729 Simvastatin + β - hydroxy Acid Antihyperlipidemic Human Plasma EDTA LC/MS/MS API 4000 0.25 32.0
    730 Simvastatin + Simvastatin acid Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 4000 0.200
    0.200    		 100
    100
    731 Simvastatin + Simvastatin Acid Antihyperlipidemic Human Plasma Na Heparin LC/MS/MS API 4000 0.50
    0.50    		 200
    200
    732 Simvastatin + Simvastatin Hydroxy Acid Antihyperlipidemic Human Plasma K3EDTA LC/MS/MS API 5500 0.20
    0.10    		 200
    100
    733 Sirolimus Immunosuppressant Human Blood EDTA LC/MS/MS API 4000 0.40 40.0
    734 Sirolimus (Sensitive) Immunosuppressant Human blood K3EDTA LC/MS/MS Premier XE 0.10 50.0
    735 Sirolimus immunosuppressants Human blood EDTA LC/MS/MS LCMS-8040 0.10 40.0
    736 Sitagliptin Antihyperglycemic Human Plasma K3EDTA LC/MS/MS API 4000 2.00 800
    737 Sodium Phenyl Butyrate +
    Metabolite Phenyl acetate+
    Metabolite Phenylacetylglutamine    		 For Urea cycle disorders Human Plasma K3EDTA LC/MS/MS API 2000 5 µg/mL
    1 µg/mL
    2 µg/mL    		 750 µg/mL
    750µg/mL
    300 µg/mL
    738 Sofosbuvir Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8040 5.00 2000
    739 Sofosbuvir + Sofosbuvir GS331007 Antiviral Human Plasma K3EDTA LC/MS/MS LC 8040 5.00
    10.0    		 1500
    3000
    740 Solifenacin Urinary antispasmodic Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 125
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    741 Solifenacin (Sensitive) Antimuscarinic Human Plasma K3EDTA LC/MS/MS API 4000 0.20 130
    742 Sorafenib Anticancer Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 10000
    743 Sorafenib Anticancer Human Plasma K3EDTA LC/MS/MS API 2000 20.0 8000
    744 Sotalol Antiarrhythmic Human Plasma Na Heparin LC/MS/MS LCMS-8050 10.0 3000
    745 Spironolactone Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 250
    746 Spironolactone Antihypertensive Human Plasma K3EDTA LC/MS/MS Premier XE 0.50 250
    747 Sulfadiazine Antibacterial Human Plasma K3EDTA LC/MS/MS API 3000 250 40000
    748 Sulphamethoxazole + Trimethoprim Antibacterial Human Plasma EDTA LC/MS/MS API 4000 0.50
    0.025    		 100
    5.00
    749 Sulfamethoxazole + Trimethoprim Antibacterial Human Plasma K3EDTA LC/MS/MS API 4000 / LCMS- 8050 150
    5.00    		 30000
    1000
    750 Sumatripatan Anti-migraine Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 100
    751 Sunitinib Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 0.25 100
    752 Sulfadoxine Antibacterial Human Plasma K3EDTA LC/MS/MS API 3200 1000 400000
    753 Tacrolimus Immunosuppressant Human Blood EDTA LC/MS/MS Premier XE 0.50 100
    754 Tacrolimus Immunosuppressant Human blood EDTA LC/MS/MS Premier XE 0.25 75.0
    755 Tacrolimus immunosuppressants Human blood K3EDTA LC/MS/MS LCMS-8050 0.050 75.0
    756 Tadalafil Antihypertensive, Erectile dysfunction Human Plasma K3EDTA LC/MS/MS LCMS-8050 2.00 800
    757 Tamsulosin Prostatic hyperplasia Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.050 30.0
    758 Tamsulosin α1a-selective alpha blocker Human Plasma K3EDTA LC/MS/MS Premier XE 0.20 100
    759 Tapentadol Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.10 1200
    760 Telmisartan Antihypertensive Human Plasma EDTA LC/MS/MS API 4000 3.00 1200
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    761 Telmisartan Antihypertensive Human Plasma K3EDTA LC/MS/MS API 4000 5.00 1000
    762 Telmisartan Antihypertensive Human Plasma K3EDTA LC/MS/MS LCMS-8040 2.00 500
    763 Telmisartan + Amlodipine Antihypertensive Human Plasma K3EDTA LC/MS/MS API 2000 2.50
    0.075     		500
    15.0
    764 Temozolamide Anticancer Human Plasma Na Heparin LC/MS/MS Premier XE 100 20000
    765 Temozolomide Anticancer Human Plasma K3EDTA LC/MS/MS API 4000 100 20000
    766 Tenofovir Antiviral Human Plasma NA LC/MS/MS API 2000 5.00 1000
    767 Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 5.00 1000
    768 Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.40 50.0
    769 Tenofovir +
    Emtricitabine +
    Lamivudine    		 Antibacterial Human Plasma EDTA LC/MS/MS API 4000 4.00
    15.0
    20.0    		 800
    3000
    4000
    770 Tenofovir Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 5.00 1000
    771 Tenofovir+ Emtricitabine Antiviral Human Plasma K3EDTA LC/MS/MS API 2000 8.00
    30.0    		 1600
    6000
    772 Tenofovir +
    Emtricitabine +
    Rilpivirine    		 Antiritroviral Human Plasma K3EDTA LC/MS/MS API 4000 4.00
    20.0
    1.00    		 800
    4000
    200
    773 Tenofovir +
    Emtricitabine +
    Nevirapine    		 Antiritroviral Human Plasma K3EDTA LC/MS/MS API 4000 4.00
    20.0
    20.0    		 800
    4000
    4000
    774 Tenofovir Alafenamide Antiviral Human Plasma K3EDTA LC/MS/MS LCMS-8050 2.00 1000
    775 Tenofovir Alafenamide + Lamivudine Antiviral Human Plasma K3EDTA LC/MS/MS API 3200 2.00
    20.0    		 500
    5000
    776 Terbinafine Antifungal Human Plasma EDTA HPLC HPLC-UV 25.0 5000
    777 Terbinafine Antifungal Human Plasma K3EDTA LC/MS/MS Premier XE 10.0 3000
    778 Teriflunomide Multiple sclerosis Human Plasma K3EDTA LC/MS/MS API 3000 10.0 4000
    779 Tetrabenazine Huntington's disease Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.01 2.00
    780 Tetracycline Antibiotic Human Plasma EDTA LC/MS/MS API 4000 20.0 8000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    781 Thiamine Vtamin B1 Human Plasma K3EDTA LC/MS/MS LCMS-8050 0.20 30.0
    782 Tiagabine Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 0.50 250
    783 TTicagrelor Platelet aggregation inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 2.50 1200
    784 Ticagrelor Platelet aggregation inhibitor Human Plasma K3EDTA LC/MS/MS Premier XE 5.00 2500
    785 Ticagrelor+ Desethoxyhydroxy Ticagrelor Platelet aggregation inhibitor Human Plasma K3EDTA LC/MS/MS API 4000 2.50
    1.00    		 1250
    500
    786 Tinidazole Antiprotozoal Human Plasma K3EDTA LC/MS/MS Premier XE 50.0 30000
    787 Tizanidine Muscle Relexant Human Plasma K3EDTA LC/MS/MS Premier XE 0.10 20.0
    788 Tizanidine Muscle Relexant Human Plasma K3EDTA LC/MS/MS Premier XE 0.075 20.0
    789 Tizoxanide Antiparasitic Human Plasma K3EDTA LC/MS/MS LCMS-8050 50.0 25000
    790 Tofacitinib Rheumatoid arthritis Human Plasma K3EDTA LC/MS/MS API 3200 0.20 100
    791 Tolbutamide Antidiabetic Human Plasma K3EDTA LC/MS/MS API 3200 500 100000
    792 Tolcapone + 3-O-Methyltolcapone Reversible inhibitor of catechol- O-methyltransferase (COMT) Human Plasma K3EDTA LC/MS/MS API 4000 40.0
    2.00    		 8000
    400
    793 Tolterodine Urinary Iincontinence Human Plasma EDTA LC/MS/MS API 3000 0.10 20.0
    794 Tolterodine + 5-Hydroxy Methyl Tolterodine Antimuscarinic Human Plasma EDTA LC/MS/MS API 3000 0.03 10.0
    795 Tolterodine+ 5-Hydroxymethyl Tolterodine Antimuscarinic Human Plasma K3EDTA LC/MS/MS API 3000 0.025
    0.025    		 10.0
    10.0
    796 Tolterodine + 5-Hydroxymethyl Tolterodine Urinary Iincontinence Human Plasma K3EDTA LC/MS/MS API 4000 0.10
    0.10    		 10.0
    10.0
    797 Topiramate Anticonvulsant Human Plasma CPDA, EDTA LC/MS/MS API 4000 18.0 5000
    798 Topiramate Anticonvulsant Human Plasma EDTA LC/MS/MS API 4000 5.00 5000
    799 Topiramate Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 5.00 5000
    800 Topiramate Anticonvulsant Human Plasma K3EDTA LC/MS/MS API 4000 2.00 1000
  • Validated Method List (Generics)
    Sr. No. Drug Name Theraputic Class Matrix Anti-Coagulant Method Equipment LLOQ(ng/mL) ULOQ(ng/mL)
    801 Torsemide Antihypertensive Human Plasma EDTA LC/MS/MS API 3000 20.0 6000
    802 Torsemide Diuretic, Antihypertensive Human Plasma K3EDTA LC/MS/MS API 2000 25.0 12000
    803 Torsemide Antihypertensive Human Plasma K3EDTA LC/MS/MS API 2000 100 25000
    804 Total Iron Iron Defficiency Anaemia Human Plasma NA ICP OES Optima 8000 500 60000
    805 Tramadol hydrochloride Analgesic Human Plasma K3EDTA LC/MS/MS LCMS-8050 3.00